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INTRODUCTION
"No  stretch  of  chemical  or  physical  imagination  will  permit  so
heterogeneous a group of compounds (as renal stones) to be ascribed to a
common origin, or their  disposition in the kidney, ureter or bladder to  be
uniformly charged to an identical cause."
- (Howard Kelly)
India has been referred to as the medicinal garden of the world. India
comes under the 12 mega biodiversity centers having 45,000 plants species. In
India around  20.000  medicinal plants species have been recorded, but around
500  traditional  communities  use  800  plant  species  for  curing  the  diseases.
Today  around  50%  of  world  population  is  totally  depends  upon  the  plant
derived products as a primary health care with no side effects (Ankur et al.,
2010).
 Nature  bestowed our  country with  an  enormous wealth  of  medicinal
plants; ants have been used as traditional healthcare system from the centuries.
The World health Organization (WHO) has listed  20,000  medicinal plants in
globally in which contribution of India is  15-20  %. The WHO reported that
80%  of  global  countries  depend  on  the  medicinal  plants.  A large  body  of
evidence has collected to show potential of medicinal plants used in various
traditional systems. In the last few years more than  13,000  plants have been
studied for the various diseases and ailments in all over the world (Ankur et al.,
2010).
 Nephrocalcinosis and uro (nephro) lithiasis frequently coexist and the
terms  often  loosely  combined  when  describing  patients  with  urinary  stone
disease,  whether  they  are  etiologically  distinct  is  unclear,  although  it  is
generally  believed  nephrocalcinosis  represents  one  end  of  the  spectrum  of
urinary stone disease, ever, although nephrocalcinosis is often associated with
urinary stones  do  not  have  macroscopic  nephrocalcinosis  (David.A.Warrell,
2003).
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 Stone formation in the kidney is one of the oldest and most wide spread
disease  known  to  man.  Urinary  calculi  have  been  found  in  the  tombs  of
Egyptian  mummies  dating  back  to  4000  BC  and  in  the  graves  of  North
American Indians from 15000-1000 BC. Reference to stone formation is made
in the early Sanskrit documents in India between 3000 and 2000 BC.
Urinary stone  disease  has  afflicted  humankind  since  antiquity  and  can
persist, with serious medical consequences, throughout a patient's lifetime. In
addition, the incidence of kidney stones has been increased in western societies
in the last five decades, in association with economic development (Bahuguna
et al., 2009).
The recurrence of  urolithiasis  represents  a  serious  problem,  as  patients
who have  formed a  stone  are  more  likely  to  form another,  and  thus  stone
prevention  is  highly  recommended.  Currently,  open  renal  surgery  for
nephrolithiasis is unusual and usual only rarely, since the introduction of ESWL
(Extracorporeal  Shock  Wave Lithotripsy).  which  has  revoltunised  urological
practice  and almost  become the   standard  procedure  for eliminating kidney
stones. However, in addition to the traumatic  effects of shock waves, persistent
residual  stone  fragments,  and  the  possibility  of  infection,  suggest  that
ESWL(Extracorporeal Shock Wave Lithotripsy) may cause acute renal injury, a
decrease in renal function and an increase in stone recurrence. Further more,
although some drugs used to prevent the disease have some positive effects,
they are not effective in all  and often have adverse effects that compromise
their  use  in  long-term  Medicinal  treatment.  Alternative  treatment  using
phytotherapy  has  been  sought;  indeed,  in  recent  years  there  has  been  a
resurgence of interest in medicinal plants that are effective safe and culturally
acceptable (Atmani, et al., 2003).
Many remedies have been employed during ages to treat renal stones.
Most of remedies were taken from plants and proved to be useful, though the
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rational behind their use is not well established except for a few plants and
some proprietary composite herbal drugs and they are reported to be effective
with no side effects. The present day medical management of nephrolithiasis is
either costly or not without side effects. Hence the search for antilithiatic drugs
from natural sources has greater assumed importance (Atef M. Al-Attar., 2010).
  The present study evaluated for the  possible therapeutic potential  of
aqueous extract  from the leaves of  Clitoria ternatea (L)  in experimentally
induced calcium oxalate urolithic rats and its diuretic potential.
The urinary system is the main excretory system and consists of  the
following  structures.  2  kidneys,  2  ureters  ,  Urinary  bladder,  Urethra.  The
urinary system plays  a  vital  part  in  maintaining  homeostasis  of  water  and
electrolyte  concentrations  with  the  body.  The  kidneys  produce  urine  that
contains metabolic waste products, including the nitrogenous compounds urea
and uric acid, excess ions and some drugs.
1. KIDNEY
 The kidneys lie on the posterior abdominal wall, one on each side of the
vertebral  column,  behind  the  peritoneum  and  below  the  diaphragm.  They
extend from the level  of the 12th thoracic vertebra to the 3rd lumbar vertebra,
receiving some protection from the lower rib cage. The right kidney is usually
slightly  lower  than  the  left  probably  because  of  the  considerable  space
occupied by the liver.
 Kidneys are bean-shaped organs, about 11 cm long, 6 cm wide, 3 cm
thick and 150g. They are embedded in, and held in position by, a mass of fat. A
sheath of fibroblastic renal fascia encloses the kidney and the renal fat (Ross
and Wilson. 2006).
Functions
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• Formation and secretion of urine.
• Production  and  secretion  of  erythropoietin,  the  hormone  that  controls
formation of red blood cells.
• Production and secretion of rennin, an important enzyme in the control of
blood pressure.
2.RENAL DISEASE
Renal disease can be classified into five different physiological categories:
• Acute renal failure, in which the kidneys stop working entirely or almost
entirely.
• Chronic  renal  failure,  in  which  progressively  more  nephrons  are
destroyed  until  the  kidneys  simply  cannot  perform all  the  necessary
functions.
• Hypertensive kidney disease,  in which vascular  or glomerular  lesions
cause hypertension but not renal failure. 
• Nephrotic  syndrome,  in  which  the  glomeruli  have  become  far  more
permeable so that large amounts of protein are lost into the urine,
•  Specific tubular abnormalities that cause abnormal reabsorption or lack
of reabsorption of certain substances by the tubules.
2.1. Acute Renal Failure
"A clinical disorder of sudden cessation of renal function characterised
by uraemia.  and disturbance  in  body fluid  and  electrolyte  balance,  with  or
without 'accompaniment of oliguria."
The causes of acute renal failure can be divided into three main categories  
a) Acute renal failure  resulting from decreased blood supply to the kidneys;
this condition is often referred to as pre renal acute renal failure to reflect the
fact that the abnormality occurs in a system before the kidneys. This can be a
consequence  of  heart  failure  with  reduced  cardiac  output  and  low  blood
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pressure or conditions associated with diminished blood volume and low blood
pressure, such as severe haemorrhage.
b)  Intrarenal  acute  renal  failure  resulting  from  abnormalities  within  the
kidney  itself.  including  those  that  affect  the  blood  vessels,  glomeruli,  or
tubules. 
c)  Postrenal   acute  renal  failure,  resulting  from obstruction  of  the  urinary
collecting system anywhere from the calyces to the outflow from the bladder.
The most common causes of obstruction of the urinary tract outside the kidney
are kidney stones caused by precipitation of calcium, urate or cystine (Guyton
& Hall, 1991).
2.2. Chronic renal Failure
"A symptom complex resulting from renal insufficiency (uraemia), and
is  characterized  by nitrogen retention  acidosis  and anaemia".  The condition
develops from a number of renal and extra renal disorders , involving the renal
parenchyma  or  obstruction  of  the  excretory  tract,  which  include  chronic
nephritic syndrome , chronic pyelonephritis, diabetic glomerulosclerosis, acute
tubulo interstitial nephritis , benign nephrosclerosis polycystic kidney disease .
bilateral cortical necrosis, massive renal infarct, addison's disease. disseminated
lupus erythematous infections and exposure to nephrotoxins. It also develops
from the conditions, which predispose to acute renal failure. On the other hand,
there may not be any previous precipitating factor in the development of the
condition (Hossain. 2004).
2.3. Urinary tract obstruction
Urinary tract obstruction or obstructive uropathy can occur at any point
in the urinary tract,  from the kidneys to the urethral  meatus.  Certain points
along  this  path  are  more  susceptible  to  obstruction.  The  three  points  of
narrowing  along  the  ureter  include  the  uretero  pelvic  junction  (UPJ),  the
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crossing  of  the ureter over the area  of  pelvic brim (the iliac vessels), and the
uretero vesicle junction (UVJ).  It  can develop secondary to calculi,  tumors,
strictures,  and anatomical  abnormalities.  (Obstructive  uropathy can result  in
pain, urinary tract infection, loss in renal function, or possibly, sepsis or death.
Urinary tract  obstruction impedes urine  flow.  This  obstruction causes
distention  of  the  urinary  tract  proximal  to  the  point  of  obstruction.  The
distention is caused by increased pressure and can result in pain, which may be
the first sign of obstruction. Distortion of the urinary tract and renal failure can
develop; the severity depends on the degree and duration of obstruction. When
the urinary tract  is  obstructed,  urine  stasis  can occur;  predisposing to  urine
infection. The clinical presentation of urinary tract obstruction varies with the
location,  duration,  and  degree  of  obstruction.  Thus,  a  thorough history and
physical examination are key in the patient evaluation (Edward David Kim et
al.,2005). 
3.KIDNEY STONES
Calculi,  or  renal  stones  (nephrolithiasis),  are  masses  of  crystals  and
protein  and are a common cause  of  urinary tract obstruction in adults. Renal
stones account for 1 of 1000 hospitalizations, with an incidence at autopsy of
approximately 5%. A significant  number of  patients are treated in outpatient
settings. Approximately 1 % of the U.S. population will have a renal will have
a renal stone at some time. Three major kinds of renal stones are
(1) Calcium oxalate
(2) Struvite (magnesium, ammonium, phosphate) and
(3) Uric acid
3.1. Epidemiology
Kidney stone  disease  is  a  multi  factorial  disorder  resulting  from the
combined influence of epidemiological, biochemical and genetic risk factors.
Kidney stones  are  of  four  types.  The  overall  probability of  forming  stones
differs in various parts of the world and is estimated as 1-5% in Asia, 5-9% in
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Europe, 13% in North America and the recurrence rate of renal stones about
75% in  20  years  span.  It  occurs  both  in  men   and  women but  the  risk  is
generally  high  in  men  and  is  becoming  more  common  in  young  women
(Sandhya et al., 2010)
The  incidence  of  urolithiasis  is  very  common  in  Northern  India
compared to southern state. It is speculated that higher incidence may be due to
wheat diets.  People  living  in rocky areas, where the climate is hot and dry,
seem to be more to urinary calculi disease (Chitme, et al., 2010)
The temperature rise worldwide due to the effects of global warming, it
has been predicted that there could be an increase of 1.6-2.2 million lifetime
cases of kidney stone by 2050, particularly in the southeast regions of the USA
(Andrew P.Evan.,2010)
Figure:1Kidney Stone
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Etiology
Several  Etiological  factor  contribute  to  the  pathogenesis  of  stone
formulation
• Geography
 Kidney stone  incidence  varies  in  different  parts  of  the  world,  thus
projecting the significance of the stone belt areas. The effect of geography on
the  incidence  of  stone  formation  may  be  direct,  through  its  effect  on
temperature;  high  temperatures  increase  perspiration,  which  may  result  in
concentrated urine, which in turn promotes increased urinary crystallization.
• Age & Sex
The disease affected all age groups from less than 1 year old to
more than 70, a male to female ratio of 2:1.
• Nutritional aspects
An unbalanced diet  or particular  sensitivity to various foods in stone
formers can lead to urinary alterations such as hypercalciuria, hyper oxaluria
hypocitrauria, hyperuricosauria, and excessive acid urinary pH.
• Diet
Some reports have described that vegetarians are at lower risk for stone
formation in contrast to non-vegetarians
• Water intake
Super  saturation  of  the  urinary  environment  with  stone  -forming
constituents  is  a  prerequisite  for  calculus  formation  and  increased  fluid
consumption  results  in  excretion  of  higher  volume  of  urine,  which  is  less
supersaturated with stone –forming constituents.
• Body weight
Overweight  condition  and  obesity  was  found  in  59.2%  of  men  and
43.9% of  women and both these  conditions were strongly associated with an
elevated  risk  of  stone  formation  in  both  genders  due  to  increased  urinary
excretion of promoters but not inhibitors  of calcium oxalate  stone formation.
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The  overweight  and  obese  men  are  more  prone  to  stone  formation  than
overweight women.
• Kidney stone and other diseases
It has been proposed that essential hypertension, cardiovascular diseases
(CVD), diabetes, and other medical conditions predispose to stone disease
• Recurrence
The  recurrent  nature  of  stone  disease  is  a  well-recognized  Clinical
problem. Male gender, multiple stones, stone location, residual fragments and
some anatomic or functional urinary tract abnormalities are known to be major
risk factors for recurrence.
• Occupation
The role of occupation in stone formation is highly debated. Kidney-
related  complications  are  on  the  increase  because  of  geographic  factors
residence in the "stone belt, occupation related lifestyle changes - in case of
indoor occupation - sedentary habits, stress, unhealthy dietary plan in terms of
healthy  or  over  healthy  food  intake,  irregular  food  habits  and  fluid  intake
(intake  of  juices  and  beverages  instead  of  water)  or  the  other  spectrum  of
physical manual labour - involving working outside exposed to heat and sun,
low  socioeconomic  status,  malnutrition  and  reduced  fluid  intake.”  Some
experts speculated that this increased risk might be due to a hormone called
vasopressin, which is released during stress, which increases the concentration
of urine.
Molecular Aspects
Stone disease is a multifactorial disease; the causes of calcium oxalate
stones  are  hetrogeneous  and  might  involve  both genetic  and  environmental
factors.
Although extensive genetic studies were carried out, no chromosomal
mapping  has  been  conducted  in  patients  with  stones  and  idiopathic
hypercalciuria (IH). The only conclusive evidence through genetic studies is
that urolithiasis is a  polygenic  defect and partly penetrative (Sandhya et al.,
2010)
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3.3. Mechanism of calcium oxalate renal stone formation
Pathophysiologic  mechanisms of  stones are  complex,  mainly because
stone  disease-  polygenic,  multifactorial  disorder  that  involves  an
interrelationship  between  kidney,  bone,  and  intestine.  Much effort  has  been
undertaken in recent years to delineate the pathophysiologic process that leads
to the formation of renal calculi. There are distinct stone phenotypes and the
cascade of events leading to kidney stone  formation varies depending on this
phenotype. Different mechanisms of stone formation have been described for
numerous stone types and clinical situations. (Gnessin et al., 2010).
The formation of  renal  stones  is  a  consequence of  increased urinary
supersarturation with subsequent formation of crystalline particles. Since most
of  the  solid  particles  crystallizing  within  the  urinary  tract  will  be  excreted
freely,  particle  formation  is  by  no  means  equivalent  to  symptomatic  stone
disease. However, when solid particles are retained within the kidney, they can
grow to become full-size ones. Crystal-cell interaction is the next step, and is
also promoted by renal  tubular injury.  Since crystal  formation is  a common
phenomenon in  human urine  and  crystaluria  per  sec  is  harmless,  abnormal
retention  of  formed  particles  must  occur  when  kidney  stones  form.  Thus,
crystal-cell  interactions  may  be  highly  relevant.  The  crystals  that  are
internalized in the interstitium undergo growth and aggregation, and develop
into renal stones. Each of these processes is described in detail below.
(Tsujihata et al., 2007)
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Figure 2: Pathogenesis of Kidney Stones
Using  calcium  oxalate  stones  as  a  model,  three  categories  of  factors
(genetic, metabolic, and dietary) act in conjunction or in isolation to lead  to kidney
stone formation. The process probably needs an initiating nidus on the epithelium,
 which provides the platform for crystallization and growth.  The defect
probably includes lesions in the cells and luminal factors. 
3.3.1.Urinary super saturation and crystallization
Urinary super saturation is the driving force behind crystal formation in
the kidneys. Since formation of crystalline particles must obviously start from
super saturation. It is undoubtedly essential for stone formation. Indeed, stone
formers tend to excrete urine that is more supersaturated than that of non-stone
formers. Humans excrete millions of urinary crystals daily, indicating at least
transient  development of super saturation. It  has been suggested that with a
transit  time  across  the  kidney of  5-10  min,  residence  time  is  too  short  for
crystals to nucleate and grow large enough to be trapped. The inner diameter of
the various segments of the renal tubules ranges from 15 to 60 mm. Calcium
oxalate crystals, growing at the rate of 1-2 mm/min, cannot grow larger than a
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few  microns  and  are  therefore  excreted  with  urine  without  causing  stone
development. In tubular fluid and urine, crystallization processes are largely
dependent on solution composition. A variety of urinary constituents may affect
solution super saturation because of their activity as chelaters. For instance, by
forming soluble complexes with calcium and oxalate respectively, citrate and
magnesium reduce free ion activity and the relative super saturation of calcium
oxalate.
3.3.2. Crystal Nucleation
The initial step in the transformation from a liquid to a solid phase in a
supersaturated  solution  is  called  nucleation.  This  process  begins  with  the
coalescence of salts in solution into loose clusters that may increase in size by
addition  of  new components  or  clusters.  In  vitro  and  in  vivo  studies  have
shown that  renal  tubular  cell  injury can  promote  crystallization  of  Calcium
oxalate crystals by providing substances for their heterogeneous nucleation. In
vitro  cell degradation following renal tubular cell  injury produces numerous
membrane vesicles, which have been shown to be good nucleators of calcium
crystals. In vivo crystals observed in the renal tubules of hyperoxaluric rats are
always associated with cellular degradation products.
3.3.3. Crystal growth
 Once  crystal  nucleus  has  achieved  a  critical  size  and  relative  super
saturation remains above 1, overall  free energy is decreased by adding new
crystal  components  to  the  nucleus.  This  process  is  called  crystal  growth.
Crystal growth is one of the prerequisites for particle formation and thus for
stone  formation.  In  each  step  of  stone  formation.,  crystal  growth  and
aggregation  have important  function.  The crystal  surface  binding substance,
which is found in Calcium oxalate crystals generated from whole human urine,
is  a  strong inhibitor  of  Calcium oxalate crystal  growth and contains human
serum  albumin,  1-acid  glycoprotein,  α1-microglobulin,  2-HS  glycoprotein,
retinol  binding  protein.  transferrin,  Tamm-Horsfall  glycoprotein,  and
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prothrombin.  However,  it  has been suggested that  the importance of crystal
growth  for  Calcium  oxalate,  the  most  abundant  stone  component,  is
questionable. Since the rate of  Calcium oxalate crystal growth is low and the
transit  time  of  tubular  fluid  through  the  kidney  amounts  to  only  several
minutes;  it  has been calculated  that   the  probability  of  a  single particle
achieving a pathophysiologically relevant size by the process of crystal growth
alone is extremely low, even if growth proceeds at an uninhibited rate of 2 mm
per  minute.  The inhibitory effect  of  fibronectin  (FN),  a  multifunctional  α2-
glycoprotein distributed throughout   the extracellular matrix and body fluids,
on Calcium oxalate crystal growth is small, considering the quantity normally
excreted. Fibronectin at a concentration of 0.5 mg/mL only 9.9% inhibition of
Calcium oxalate crystal growth. (Tsujihata M et al., 2007)
3.3.4. Crystal aggregation
The crystals of solution is sticking together to form larger particles
is  called  aggregation  process.  Some  researchers  have  proposed  that  crystal
aggregation is  the  most important  step in  stone formation.  Although crystal
growth is a definite step of Calcium oxalate renal stone formation; the process
of growth is so slow that crystals cannot become large enough to obstruct the
renal tubules and be retained there by this mechanism alone, as several minutes
are required for the tubular fluid to pass through the kidney.  For this reason,
the  more  critical  step  is  thought  to  be  crystal  aggregation.  All  models  of
Calcium  oxalate  urolithiasis  concede  that  crystal  aggregation  is  probably
involved crystal retention within the kidneys, since aggregation of crystals can
have  a  considerable  effect  on  particle  size,  and  aggregated  crystals  are
commonly found in urine and renal stones.
Crystal  aggregation  is  promoted  by  viscous  binding,  implying  that
crystal foreign compounds with multiple binding sites, such as abnormally self-
aggregating Tamm- Horsfall glycoprotein or other macromolecules, attach to
crystal surfaces and act as a kind of glue. The inhibitory effect of Fibronectin
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on  Calcium oxalate  crystal  aggregation  was  found  to  be  47.7%  at  the  0.5
mg/mL physiological concentration of excreted Fibronectin.
3.3.5. Crystal-cell interaction
The  mechanisms  of  crystal-cell  interaction  are  thought  to  be  very
complex, and many of them remain unexplored. Crystallization is caused by
the condition of urinary super saturation. Then, the crystals that have formed
attach to renal tubular epithelial cells and are taken into them. The process of
attachment or endocytosis of crystals to renal tubular cells is generally known
as  crystal-cell  interaction.  Adhesion  of  14C-labeled  calcium  oxalate
monohydrate (COM) crystals was detected as early as 30's after their addition
to  cultures  of  BSC-1  cells,  followed  by  their  uptake,  whereas  calcium
phosphate crystals  did not  exhibit  uptake to  the  same extent.  The structural
characteristics of the binding and uptake of COM crystals by BSC-1 cells have
been characterized by scanning electron microscopy (SEM). Microvilli on the
apical  cell  surface appear to make initial  contact  with  the crystal  before  its
internalization.  Transmission  electron  microscopy  (TEM)  confirmed  that
endocytosis of COM crystals by BSC-1 cells occurs as early as  30  min after
exposure. These structural and functional studies of crystal-cell interactions in
culture  indicate  that  COM crystals  rapidly  adhere  to  microvilli  on  the  cell
surface and are subsequently internalized. The behavior of these cells  in vitro
provides  a  dynamic model  to  explain  the  presence  of  intracellular  Calcium
oxalate crystals in the kidneys of patients with hyperoxaluria.
In recent years, a number of investigators have emphasized that crystal-cell
interactions,  including  crystal  attachment  and  endocytosis,  are  important
processes in Calcium oxalate renal  stone formation.  Crystal-cell  interactions
are now thought to be extremely important in physiological crystal retention
and the early stages of Calcium oxalate renal stone formation. Thus, Calcium
oxalate crystals may be retained in the kidney to form stones by binding to the
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apical  surface  of  tubular  cells  and  subsequently  undergoing  endocytosis
(Tsujihata et al., 2007).
Fig 3: Scheme of the process of calcium oxalate renal stone formation
Types of stone
Four main types of stones are encountered in clinical practice calcium
stones predominate, and a majority of these are composed of calcium oxalate.
Whatever their composition, stones are organized masses of crystals that grow
on the surfaces of the renal papillae whenever the excretory burden of poorly
soluble materials. In the cases of calcium and cystine stones, the main causes
are over excretion of calcium, uric acid, oxalate, cystine, respectively. Uric acid
stones can be caused by over excretion of uric acid but an abnormally low urine
pH is  usually more important  in pathogenesis.  Struvite  stones  are  produced
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Urinary super saturation
Crystal- Cell interaction
Crystal growth 
Stone formation
Renal tubular injury
crystal aggregation
only by bacteria that possess the enzyme urease and therefore are a result of
urinary infection (Schrier , 1995).
Table 1: Types of renal stones
Major constituent Crystal type Approximate % of all
stones
Calcium Calcium oxlate
Hydroxyapatite (CaPO4)
Brushite
75
Uric acid Uric acid 5
Cystine Cystine (amino acid) 5
Struvite- carbonate MgNH4PO4 and CaCO3 20
3.4.1. Calcium stones
Hypercalciuric states, hyperuricosuria, and hyperoxaluria are the main
remediable causes of calcium stones.
i. Hypercalciuria
The  association  between  increased  urinary  calcium  excretion  and
calcium oxalate renal stones has been reported and about 30-60% of patients
with calcium oxalate stones have increased urinary calcium excretion in the
absence of raised serum calcium levels. Urinary calcium excretion depends on
dietary  calcium  intake,  which  varies  between  400-2000  mg/day.  Thus,  the
diagnosis of hypercalciuria requires a strict definition (Gupta et al., 2002).
• Excretion  of  greater  than  200  mg  of  calcium/24  hrs  after  one  week
adherence to a 400 mg of calcium and 100 mg of sodium diet.
• Excretion of greater than 4 mg of calcium/kg body weight or greater
than 7 mmol in men and 6 mmol in women.
• Excretion  of  urinary  calcium  of greater  than  0.11  mg/100  ml  of
glomerular filtrate.
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• For the purpose of diagnosis and management hypercalciuria is divided
into three types:
a) Absorptive hypercalciuria 
Where the primary abnormality involves the increased intestinal
absorption of calcium. This is further divided into three types.
Type  1  -  the  intestinal  hyper  absorption  of  calcium  exists  irrespective  of
calcium restricted diet.
Type  2  -  a  variant  where  the  patients  exhibit  increased  urinary  calcium
excretion while on their normal diet but normal calcium excretion on a low
calcium, low sodium diet.
Type 3 - a variant with renal phosphate leak causing hypo phosphatemia which
leads  to  increased renal  synthesis  of  1,  25  dihydroxy caicitriol  resulting  in
hyper absorption of calcium and the syndrome of hypercalciuria.
b) Renal hypercalciuria characterized by primary renal leak of calcium
This  involves  primary  renal  wasting  of  calcium  with  consequent
reduction in serum calcium stimulating parathyroid production. The increased
parathyroid results in hydroxylation of 25, hydroxy Vit D3  to 1, 25, dihydroxy
Vit D3 increasing intestinal calcium absorption. These effects restore the serum
calcium to normal at the expense of increased parathromone 1,25, dihydroxy
Vit D3.
Two  factors  which  differentiate  renal  hypercalciuria  from  absorptive
type  hypercalciuria  are  elevated  fasting  urinary  calcium  and  stimulated
parathyroid function. There is a more generalized disturbance in renal tubular
function  with  renal  hypercalciuria  as  shown  by  an  exaggerated  natriuretic
response to thiazide and exaggerated calciuric response to carbohydrate load.
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c) Resorptive  hypercalciuria  characterized  by  increased  bone
demineralaiztion
Hypercalciuria  results  from  excess  Parathromone  dependent  bone
resorption  as  well  as  enhanced  intestinal  absorption  of  calcium  caused  by
Parathromone   itself  or  by  a  Parathromone  dependent  synthesis  of  1,25
dihydroxy Vit D3. Although Parathromone causes increased tubular absorption
of calcium, the increase in the filtered load of calcium overwhelms this and
results in excessive urinary calcium excretion (Gupta et al., 2002).
ii. Hyperoxaluria
Hyperoxaluria  is  related  to  calcium  oxalate  nephrolithiasis  and  is
usually of three types.
a) Primary hyperoxaluria
It is of two types:
Type 1- an autosomal recessive inborn error of metabolism characterised
by nephrolithiasis,  tissue  depostion  of  oxalate  and  death  from renal  failure
before the age 20 in untreated patients. There is increased excretion of oxalic,
glycolic and glyoxalic acids due to the defect of enzyme alanine glyoxalic acid
aminotransferase (AGT)  in the
liver.
           Type 2- a rare varient occurs due to the deficiency of hepatic enzyme D-
glycerate dehydrogenase and glyoxlate reductase, which leads to increase in
urinary oxalate and glycerate excretion.
Increased  hepatic  conversion  occurs  due  to  the  pyridoxine  deficiency,
ethylene glycol ingestion and methoxy flurane anaesthesia.
b) Increased oxalate absorption
Conditions  causing  increased  oxalate  absorption  leading  to
hyperoxaluria  are  malabsorption  occurring  from  bowel  resection,  intrinsic
disease or jejunoileal bypass, which leads to increased colonic permeability of
oxalate as a result of exposure of colonic epithelium to bile salts; further the
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unabsorbed  fats  bind  with  the  calcium making  the  dietary  oxalate  free  for
absorption.
c) Mild metabolic hyperoxaluria
Increased urinary oxalate excretion is seen in 0.3-0.5% of patients with
calcium stones. Increased dietary protein intake and altered renal excretion of
oxalate  have  been  predicted  as  an  important  cause  for  increased  oxalate
excretion (Gupta et al.,2002).
iii. Hyperuricosuria
Patients with gout or hyperuricosuria form calcium oxalate stones apart
from the  uric  acid  stones.  The most  important  cause  for hyperuricosuria  is
excessive purine intake. Apart from this some patients have tendency to excrete
more uric acid in the urine than do the normal subjects even on purine-free diet
due to the increased uric acid production from endogenous purine metabolism.
Hyperuricosuria may be seen in patients with specific enzyme defects such as
increased activity of 5 phosphoribosyl 1-pyrophosphate synthetase, the enzyme
that initiates purine metabolism and Lesh-Nyhan syndrome, with deficiency or
complete lack of hypoxanthine guanine phosphoribosyl transferase resulting in
shunting  of  hypoxanthine  to  xanthine/uric  acid  pathway  leading  to
hyperuricosuria and hyperuricimea. Myeloproliferative disorders such as acute
leukemia are important causes in childhood (Gupta et al., 2002).
3.4.2. Struvite stones
Struvite stones are caused by urinary infections with urease producing
organisms, the most common being Proteus mirabilis. Less common pathogens
include  Klebsiella,  Enterobacter,  or  Pseudomonas.  (E.  coll  is  not  a  urease
producing  organism.)  Urease  cleaves  each  mole  of  (soluble)  urea  into  two
moles of (relatively insoluble) ammonium.
  NH2CONH2+H2O      2NH3+CO2
 2NH3+H2O    2NH+ + OH-
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 CO2+H2O    H+ + HCO3- H+ + CO3 2-
As  this  cleavage  occurs,  free  H+  is  bound  to  NH3 to  produce  NH4,
yielding  OH-  from water,  is  making  urine  more  alkaline.  Phosphate  is  less
soluble  at  alkaline  versus  acidic  pH,  so  phosphate  precipitates  onto  the
insoluble ammonium products, yielding magnesium ammonium phosphate. As
the bacteria that  produce urease  remain in  urine and within  the  stone,  they
continue to produce urease, and continue to cleave urea, and so large (staghorn
shaped) stones may develop quite rapidly and fill the calyceal spaces of the
kidney.
3.4.3. Uric acid stone
Second only to calcareous stones in prevalence, is uric acid calculi. Uric
acid exists in equilibrium with urate at a pK of 5.5. As pH falls below 5 .5 ,  the
concentration of dissociated uric acid greatly exceeds that of urate. Uric acid
stones can result from either hyperuricosuria, acidic urine pH. or both. In the
absence of hyperuricosuria, low urinary pH also can convert urinary urate into
the sparingly soluble  uric  acid.  Excessively low urine pH  is  much  more
common than hyperuricosuria as a cause of uric acid stones. Secondary causes
of low pH can result from excessive acid load or alkali loss, such as arises with
chronic diarrhoea.
Studies have emphasized the increasing importance of insulin resistance
in  the  pathogenesis  of  uric  acid  stones.  High  body-mass  index,  glucose
intolerance, and over type 2 diabetes are common in uric acid stone formers.
Conversely,  diabetic  stone  formers  have  a  30-40% rate  of  uric  acid  stones
compared with the 5-8% rate of uric acid nephrolithiasis in the general stone
forming population.  The results  of  a retrospective analysis  74 of  more than
4000 patients show that individuals with a high body-mass index tend to have
low urinary pH. These findings  link uric acid stones and excessively acidic
urine to obesity and type 2 diabetes. Metabolic studies in people indicate that
uric acid stone formers maintain acid-base balance, but tend to have higher acid
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production  of  a  non-dietary  origin  and  use  titratable  acid  rather  than
ammonium to excrete their acid (Orson W Moe., 2006).
3.4.4. Cystine stone
Cystine stones are caused by inherited defects of renal transport not, as
suggested by the father of genetic disease, Sir Achibald Garrod, by a defect in
metabolic enzymes. Incidence and prevalence rates vary greatly dependent on
geographic area and method of  screening,  so  the actual  allelic  frequency is
difficult to estimate. However, an incidence of one per 20.000 is often quoted.
Inactivating mutations in one of the two possible subunits (rBAT or bO+ATl) of
the multi substrate basic amino acid transporter in the kidney leads to urinary
wasting  of  a  host  of  amino  acids,  such  as  cystine,  arginine,  lysine,  and
ornithine. The phenotype is cystine stones because only cystine is soluble in
urine.  The  solubility  of  cystine  is  improved  with  alkaline  pH  and
homodimerisation of cystine to cysteine. The old clinical classification is now
correlated  with  a  molecular  classification:  in  type  I  cystinuria  (rBAT
mutations), heterozygotic carriers have concentrations of urinary cystine within
the  normal  range;  in  non-type  I  (ie.,  type  II  and  III;  b0+AT  mutations)
intermediate aminoaciduria is seen in heterozygotes (Orson W Moe., 2006). 
3.4.5. Xanthine stone
Xanthine stones are secondary to a congenital deficiency of xanthine
oxidase.  This  enzyme  normally  catalyzes  the  oxidation  of  hypoxanthine  to
xanthine and of xanthine to uric acid. It is of interest that allopurinol, used to
treat hyperuricosuric calcium nephrolithiasis and uric acid lithiasis, produces
iatrogenic  xanthinuria.  Blood  and  urine  levels  of  uric  acid  are  lowered,
hypoxanthine and xanthine levels  are  increased;  however,  there  are  no case
reports of xanthine stone formation resulting from allopurinol treatment. It is
unlikely that allopurinol completely inhibits xanthine oxidase. Approximately
25% of patients with a xanthine oxidase deficiency develop urinary stones. The
stones are radiolucent and are tannish-yellow in colour. High fluid intake and
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urinary alkalization are required for prophylaxis. If stones reoccur, a trial of
allopurinol and a purine-restricted diet is appropriate (Smith, 1995).
3.4.6. Rare stone
In all series of stones analysed. Between 1 and 2 percent consist of a
range of rare constituents derived from either some hereditary or congenital
inborn  error  of  metabolism,  such  as  cystinuria  (not  to  be  confused  with
cystinosis)  ,  xanthinuria ,  or 2.8-dihydroxyadeninuria ,  or  from a prescribed
drug or metabolite , which is relatively insoluble in urine .
Examples are silica (from excess ingestion of the antacid magnesium
trisilicate  or  from the  use  of  pectin  and  silicum to  thicken  milk  for  infant
feeding), sulphonamides, indinavir and triamterene. All stones contain a small
percentage by weight of mucoproteinaceous matrix.Some stones consist almost
entirely of mucoprotein, and usually result from inflammation of the urinary
tract in patients whose urine is not sufficiently supersaturated to mineralize the
organic matrix (David A. Warrell, 2003).
3.5. Modifiers of crystallization
One factor that might affect the kinetics of the process involved is the
presence or absence in urine of so called modifiers of crystallization, claimed
to be of particular importance in the formation  of  calcium containing stones.
One group of crystallization modifiers is said to retard the rate of growth and/or
aggregation of crystals,  or the binding of calcium containing crystals to cell
walls. These are known as inhibitors of crystallization and include magnesium,
citrate  pyrophosphate,  ADP,  ATP,  at  least  two  phosphopeptides,
glycosaminoglycans,  Tamm-Horsfall  protein,  ephrocalcin,  calgranulin,
fibronectin,  various  plasma  proteins,  osteopontin  (uropontin),  α 1
microglobulin, β2 microglobulin. Urinary prothrombin fragment 1, and inter- α
-trypsin inhibitor. Of these, urinary citrate is probably the most important. The
second group of modifiers is claimed to promote one or more of the processes
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involved in crystallization. These are known as promoters of stone formation
and include matrix substance A, various uncharacterized urinary proteins and
glycoproteins,  and polymerizes form of Tamm-Horsfall protein (uromucoid).
However the clinical  importance of these compounds in the pathogenesis of
stone formation remains unclear (David .A. Warrell. 2003).
3.5.1. Inhibitors
Inhibitors  of  calcium  stone  formation  prevent  crystal  growth  and
aggregation  by  coating  the  surface  of  growing  calcium  crystals  or  by
complexing with calcium and oxalate (Basavaraj et al., 2007).
a) Citrate
Citric acid is a tricarboxylic acid that circulates in blood complexed to
calcium,  magnesium  and  sodium  at  physiological  pH  of  7.4.  Most  of  the
circulating  citrate  is  derived  from  endogenous  oxidative  metabolism.  It  is
filtered  freely  through  the  glomerulus.  Approximately  75%  of  the  filtered
citrate is reabsorbed in the proximal convoluted tubule. Apart from idiopathic
causes,  other  etiological  factors  of  hypocitraturia  are  -  use  of  drugs  like
acetazolamide  and  thiazides,  renal  tubular  acidosis,  urinary  tract  infection,
hypokalemia, hypomagnesemia and inflammatory bowel disease.
Thiazide diuretics may induce hypocitraturia owing to hypokalemia with
resultant intracellular acidosis. Hypocitraturia is a common disorder occurring
in >50% of patients with nephrolithiasis. Citrate has been widely studied for its
stone inhibiting action in urine and it has been found to be particularly effective
against the calcium oxalate and phosphate stones. Citrate appears to alter both
calcium oxalate monohydrate and calcium phosphate crystallization.
b) Pyrophosphates
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At low concentrations,  16 mM. pyrophosphate  inhibits  COM crystal
growth by 50%. The urinary pyrophosphate level is in the range of 20-40 mM
and therefore, theoretical levels are high enough to inhibit Calcium oxalate and
Calcium  Phosphate  crystallization.  Pyrophosphate  and  diphosphate  have
shown to inhibit the precipitation of Calcium Phosphate, where as diphosphates
also  inhibits  the  growth  of  apatite  crystals.  Pyrophosphate  will  reduce  the
absorption of calcium in the intestine. Oral administration of orthophosphate
has shown little benefit in prevention of stone recurrence. Conversely, patients
treated  in  a  randomised,  placebo-controlled  study  recorded  increased  stone
formation in the orthophosphate treated group over placebo treated subjects
over  a  3-year  period.  There  is  a  lack  of  scientific  evidence  to  support
preventive role of orthophosphate.
c) Magnesium
Magnesium is  the  fourth  most  abundant  mineral  in  the  body  and  is
largely found in bones. Dietary magnesium is absorbed in the small intestines
and excreted through the kidney. Only 1% of total body magnesium circulates
in blood. In a supersaturated Calcium oxalate solution 2 mmol/L magnesium
reduced particle number by 50%. Magnesium can form complexes with oxalate
and  decreases  Struvite  stones.  Oral  intake  of  magnesium will  decrease  the
oxalate absorption and urinary excretion, in a manner similar to calcium by
binding  to  oxalate  in  the  gut.  Magnesium supplementation in  subjects  with
magnesium deficiency increases  the  excretion  of  citrate  in  urine.  However,
there  is  little  evidence  to  recommend  magnesium  therapy  in  patients  with
urolithiasis.
d) Inter-alpha-trypsin inhibitor family of proteins
Inter-α-inhibitor (Ial) belongs to the Kunitz-type protein superfamily, a
group  of  proteins  possessing  a  common  structural  element  (kunin)  and  the
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ability to inhibit serine proteases. Ial is a glycoprotein composed of 2 heavy
chains (HC1 and HC2) and one light chain, also known as bikunin.
Bikunin  circulates  free  in  plasma  and  is  excreted  in  urine  where  it
degrades further to fragments  HI I4  and HI8. Bikunin, a Kunitztype protease
inhibitor found in human amniotic fluid and urine, exhibits anti-inflammatory
and antimetastatic functions in animals and humans.  It  is expressed mainly in
the proximal tubules and thin descending segment near the  loop of  Henle. It
may  contribute  to  the  regulation  of  crystal  adhesion  and  retention  within
tubules during kidney stone formation. Furthermore, the potent inhibition of
Calcium oxalate  crystal  growth  by these  proteins,  coupled  with  the  known
presence of bikunin and its fragments in urine, suggested the possible existence
of a relationship between Ial and Calcium oxalate stone formation.
e)  Osteopontin (Uropontin)
Osteopontin  (OPN) is  a  negatively-charged  aspartic  acid  rich  protein
that inhibits growth of Calcium oxalate crystals in a supersaturated solution.
Osteopontin is intimately involved in the regulation of both physiological and
pathological mineralization. Osteopontin  is a phosphorylated protein of wide
tissue  distribution  that  is  found  in  association  with  dystrophic  calcification
including in the organic matrix of kidney stones. Osteopontin  is synthesised
within the kidney and present in the human urine at levels in excess of 100 nM.
f) Urinary prothrombin fragment 1
The blood clotting factor prothrombin is degraded into three fragments
-thrombin, fragment 1 and fragment 2. Fragment 1 is excreted in urine and is
named Urinary prothrombin fragment  (UPTF1)  and is  a  potent  inhibitor  of
Calcium  oxalate  stone  formation  in  vitro.  The  organic  matrix  of  Calcium
oxalate  crystals  contains  UPTF1,  providing  evidence  that  links  the  role  of
blood coagulation proteins with urolithiasis. UPTF1 is an important inhibitor of
Calcium oxalate crystal aggregation and adherence of crystals to renal cells. In
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South  Africa  the  incidence  of  urolithiasis  in  blacks  is  significantly  less
compared to whites. UPTF1 from the black population has a superior inhibitory
activity over UPTF1 from the white population. Further studies indicate that
sialylated glycoforms of UPTF1 afford protection against Cacium oxalate stone
formation, possibly by coating the surface of Calcium oxalate crystals.
g)  Tamm-Horsfall protein
Tamm and Horsfall isolated a mucoprotein from the human urine nearly
50 years ago, and showed that the protein was able to interact and inhibit viral
haemagglutination. Tamm-Horsfall protein (THP), also known as uromucoid, is
an 80-kDa glycoprotein synthesized exclusively in the thick ascending limb of
the loop of Henle's loop (TAL) with exception  of the macula densa. THP is the
most abundant protein in the urine of normal mammals. THP production ranges
from 30 to 60 mg/24 hr in humans. THP may be involved in the pathogenesis
of cast nephropathy, urolithiasis, and tubulointerstitial nephritis. There is good
evidence  that  the  excessive  intake  of  animal  protein  predisposes  to  stone
disease.  Much  controversy  exists  about  whether  THP is  a  promoter  or  an
inhibitor  of  crystal  aggregation.  Most  authors  believe that  it  is  an effective
inhibitor  of  COM crystal  aggregation  in  solutions  with  high pH,  low ionic
strength and low concentration of divalent ions and THP. In contrast, with low
pH, high concentrations of calcium, sodium, and hydrogen ions as well as low
THP,  inhibitory  activity  is  lost  and  it  may  even  become  a  promoter  of
aggregation.
h) Glycosaminoglycans
Glycosaminoglycans  (GAGs)  have  been  identified  as  one  of  the
macromolecules  present  in  the  stone  matrix,  chondritin  sulphate,  heparin
sulphate  and  hyaluronic  acid  are  excreted  in  the  urine.  Recently,  the  main
GAGs found in stone matrix were identified as heparin sulphate and hyaluronic
acid.  They  are  thought  to  play  an  important  role  in  Calcium  oxalate
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crystallization. GAGs concentration in the urine is too low to decrease calcium
Struvite stones.  In vitro,  GAGs have shown to act  as inhibitors of  Calcium
oxalate  crystal  growth and crystal  aggregation.  However,  investigators  have
failed demonstrate any qualitative and/ or quantitative significant difference in
total excretion of GAGs between stone formers and controls (Basavaraj et al.,
2007).
i) Renal lithostathine
Lithostathine  is  a  protein  of  pancreatic  secretion  inhibiting  calcium
carbonate crystal growth. A protein immunologically related to lithostathine is
actually  present  in  urine  of  healthy  subjects  and  in  renal  stones,  renal
lithostathine  (RL).  Immunocytochemistry  of  kidney  sections  localized  the
protein to cells of the proximal tubules and thick ascending limbs of the loop
of Henle. Because of its structural and functional similarities with pancreatic
lithostathine, it was called renal lithostathine. RL seems to control growth of
calcium carbonate crystals.  Several reports showing the presence of calcium
carbonate (CaCO3) in renal stones suggested that crystals of CaC03 might be
present  in the early steps of  stone formation.  Such crystals  might therefore
promote  Calcium  oxalate  crystallization  from  supersaturated  urine  by
providing an appropriate substrate for heterogeneous nucleation.
3.5.2. Promoters
On the cell surfaces of the kidney, cell debris, protein aggregates and
other crystals may provide analogous site for nucleation. These nucleation sites
may lower the Struvite stones required to initiate crystallisation and therefore
promote Calcium oxalate crystallization. Strong geometric similarities between
the crystals of uric acid dihydrate and COM may promote overgrowth of one
on the other, a process similar to the relationship between apatite and COM.
Evidence  suggests  that  uric  acid  and  Calcium  Phosphate  may  promote
heterogeneous nucleation. Another factor that may promote the formation and
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growth  of  intrarenal  crystals  is  ionic  calcium.  Hypercalciuria  can  decrease
inhibitor function and lead to crystallization. Furthermore, cellular responses to
newly formed crystals and factors that modulate these crystal-cell interactions
could stimulate the initiation of an intrarenal stone (Basavaraj et al., 2007).
3.6. Symptoms of kidney stones
Symptoms of kidney stones include
• Colicky pain "loin to groin" Often described as "the worst  pain ever
experienced".
• Haematuria (blood in the urine, due to minor damage to inside wall of
kidney, ureter and urethra)
• Pyuria (pus in the urine).
• Dysuria (burning on urination when passing stones (rare). More typical
of infection).
• Oliguria (reduced urinary volume caused by obstruction of the bladder
or urethra by stone or extremely rarely, simultaneous obstruction of both
ureters by a stone).
• Abdominal distention.
• Nausea/vomiting  (embryological  link  with  intestine-  stimulates  the
vomiting center).
• Fever and chills.
• Hydronephrosis
• Postrenal azotemia (when kidney stone blocks ureter)
• Frequency in micturation: Defined as an increase in number of voids per
day (>than 5 times), but not an increase  of  total urine output per day
(2500ml). That would be called polyuria.
• Dribbling of urine
• Loss of appetite
• Loss of weight
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3.7. INVESTIGATIONS
3.7.1. Laboratory Studies 
Urinalysis
Evaluate the urine for evidence of haematuria  and infection.  Approximately
85% of patients with urinary calculi exhibit gross or microscopic haematuria.
An  absence  of  haematuria  does  not  rule  out  urinary  calculi;  in  fact,
approximately 15% of patients with urinary stones do not exhibit haematuria.
Complete blood cell count
In  the  context  of  nephrolithiasis,  an  elevated  white  blood  cell  count
suggests renal or systemic infection. A depressed red blood cell count suggests
a chronic disease state or severe ongoing haematuria.
Total volume
Patients in whom stones form should strive to achieve a urine output of
more than 2 L daily in order to reduce the risk of stone formation.
Patients with cystine stones or those with resistant  cases may need a
daily urinary output of 3 L for adequate prophylaxis.
Urinary pH
Some stones, such as those composed of uric acid or cystine, are pH-
dependent,  meaning  that  they can  form only in  acidic  conditions.  Calcium
phosphate and struvite only form when the urine pH is alkaline. Although the
other  parameters  in  the  24-hour  urine  usually  identify  patients  at  risk  of
forming these stones, pH studies can be important in monitoring these patients,
in optimizing therapy with citrate supplementation, and in identifying occult
stone disease in some patients.
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Serum electrolytes
Estimation  of  creatinine,  calcium,  uric  acid,  parathyroid  hormone
(PTH), and phosphorus studies. These are needed to assess a patient's current
renal function and to begin the assessment of metabolic risk for future stone
formation.
3.7.2. Imaging studies
Plain abdominal radiography
Plain  abdominal  radiography  (also  known  as  a  flat  plate  or  kidney,
ureter,  and  bladder  [KUB]  radiography)  is  useful  for  assessing  total  stone
burden,  as  well  as  the  size,  shape,  and  location  of  urinary calculi  in  some
patients. It is also helpful in determining the progress of the stone without the
need for more expensive tests with greater radiation exposures.
Renal ultrasonography
Renal ultrasonography by itself is frequently adequate to determine the
presence of a renal stone. The study is mainly used alone in pregnancy or in
combination with plain abdominal radiography to determine hydronephrosis or
ureteral dilation associated with an abnormal radiographic density believed to
be a urinary tract calculus. Ureteral calculi, especially in the distal ureter, and
stones smaller than 5 mm are not easily observed with ultrasonography.
Intravenous urography
An  intravenous  urography (IVU)  test,  also  known as  an  intravenous
pyelography (IVP), has been the standard for determining the size and location
of  urinary  calculi  up  until  recently.  IVU  provides  both  anatomical  and
functional information.
Plain renal tomography
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Although largely replaced by helical CT scanning without contrast, plain
renal  tomography  is  often  helpful  in  finding  small  stones  in  the  kidneys,
especially in patients who are large or obese whose bowel contents complicate
observation of any renal calcifications. Plain renal tomography is also useful
for determining the number of stones present in the kidneys before a stone-
prevention program is instituted. This information is used to better differentiate
stones formed before therapy began from those formed later. (Stuart Wolf et al.,
2010).
3.8 Treatment
The  treatment  options  are  medical,  stone  retrieval  and
prophylaxis.
3.8.1. Medical Care
Depending on the result of 24 hour urine collection, there are different
treatment options for different stone types. Now there is convincing evidence
that by treating specific biochemical abnormalities, the recurrence rate can be
reduced.  The  three  most  commonly  used  classes  of  medications  for  stone
prevention are enlisted here
1. Thiazide diuretics (e.g. Hydrochlorthiazide): are used to reduce urine
calcium excretion, in patients with hypercalciuria.
2. Alkali  (e.g. Potassium citrate): are used to increase the urinary citrate
excretion in ratients with hypocitriuria.
3. Allopurinol: is used to reduce uric acid synthesis and urinary excretion
in patients which hyperuricaemia or hyperuricosuria.
4. Sodium cellulose phosphate (SCP): is used to restore normal calcium
excretion  by  reducing  intestinal  calcium  absorption.  The  SCP  may
induce  hypermagnesiuria  leading  to  increase  saturation  of  Calcium
oxalate due to reduced complexation of urinary oxalate by magnesium.
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5. Penicillamine  (Cuprimine):  are often recommended  if  drinking more
fluids does not control cystine formations.
6. Analgesic  (Diclophenac  sodium):  For  patients  with  ureteral  stones
expected to pass spontaneously tablets  of  diclophenac sodium  50  mg
administered twice daily during 3-10 days,might be useful in the risk of
recurrent pain.
7. Bisphosphonates: Decrease fasting calciuria and less marked decrease
in 24-hr calciuria.
8. Potassium  phosphate:  Increase  serum  phosphate,  increase  urine
phosphate and possible increase in urine pyrophosphate.
9. Oxalobacter  formigenes and  other  probiotics:  Decrease  oxalate
excretion
(Choubey Ankur, et al., 2010). Cystone - The Himalaya Drug C. remedy
is also prescribed by some medical practitioners.
Table 2
Cystone Formulation
Sl.
No
Herbal Drugs Quantity Added
1. Didymocarpus
peducellata
65mg
2. Saxifraga ligulata 49mg
3. Rubia cordifolia 16mg
4. Cyperus scariosus 16mg
5. Achyranhes aspera 16mg
6. Onosma bracteatum 16mg
7. Vernia cinerea 16mg
3.8.2 Surgical Care
Extracorporeal shock wave lithotripsy (ESWL)
Most  urinary  tract  calculi,  which  require  treatment,  are  currently
managed with this ESWL, which is the least invasive of the surgical methods
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of  stone  remova.  Unfortunately,  much  of the  literature  has  exposed  the
weaknesses of newer-generation lithotriptors. As a result. ESWL success rates
are not as good as they once were.
New  lithotriptors  that  have  two  shock  heads,  which  deliver  a
synchronous  or  asynchronous  pair  of shocks  (possibly  increasing  efficacy),
have attracted great interest.
The  shock head  delivers  Shockwaves  developed  from  an
electrohydraulic. electromagnetic, or piezoelectric source. The Shockwaves are
focused on the calculus, and the energy released as the shockwave impacts the
stone produces fragmentation. The resulting small fragments pass in the urine.
ESWL is limited somewhat by the size and location of the calculus. A stone
larger than 1.5 cm in diameter or one located in the lower section of the kidney
is treated less successfully.
Ureteroscopy
A small endoscope, which may be rigid, semirigid, or flexible, is passed
into the bladder and up the ureter to directly visualize the stone.
Percutaneous nephrostolithotomy
Percutaneous nephrostolithotomy allows fragmentation and removal of
large calculi from the kidney and ureter and is often used for the many ESWL
failures. A needle, and then a wire, over which is passed a hollow sheath, is
inserted  directly  in  the  kidney  through  the  skin  of  the  flank  and  effective
lithotrites can be used to rapidly fragment and remove large stone volumes
(Stuart Wolf et ah, 2010).
Panel: Recent advances in surgical management of kidney stones 
Miniaturisation of flexible ureteroscopes
• Improved ability to access all locations, including the lower pole of the
kidney, the historic stumbling block for ureteroscopic approaches
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Holmium:YAG (yttrium-aluminum-garnet) laser
• Any stone, irrespective of composition, can be fragmented
• Can be introduced through the smallest calibre endoscopes
Improved ureteral access sheaths
• Allow multiple  entries and exits  without causing repeated trauma to  the
ureter
Newly designed baskets
• Allow stones  to  be  displaced  from the  difficult-to-access  lower  pole
calyx  to  a  more  accessible  upper  pole  calyx,  where  they  can  be
fragmented ureteroscopically
• Provide  an  efficient  means  to  retrieve  stones  remote  from  the
nephrostomy tract  with a flexible endoscope,  precluding the need for
additional percutaneous punctures (Orson W Moe., 2006).
3.8.3. Prevention
Effective kidney stone prevention is dependent on the stone type and the
identification of risk factors for stone formation. An individualized treatment
plan  incorporating  dietary  changes,  supplements,  and  medications  can  be
developed  to  help  prevent  the  formation  of  new  stones.  Regardless  of  the
underlying  etiology  of  the  stone  disease,  patients  should  be  instructed  to
increase their fluid intake in order to maintain a urine output of at least 2 L/d. A
high fluid intake reduces urinary saturation of stone-forming calcium salts and
dilutes promoters of Calcium oxalate crystallization.
A high  sodium intake  increases  stone  risk  by reducing  renal  tubular
calcium  reabsorption  and  increasing  urinary  calcium.  Patients  should  be
advised to limit their dietary sodium intake to 2000-3000 mg/d. A restriction of
34
animal proteins is also encouraged since animal proteins provide an acid load
because of the high content of sulfur-containing amino acids.
A reduced intake of calcium leads to an increased intestinal absorption
of oxalate, which itself may account for an increased risk of stone formation.
Vitamin  C  has  been  implicated  in  stone  formation  because  of  in  vivo
conversion of ascorbic acid to oxalate.  Therefore,  a limitation of vitamin C
supplementation to 500 mg/d or less is recommended.
When  dietary  modification  is  ineffective,  pharmacological  treatment
should be initiated. (Butterweck et al., 2009).
4. DIURETICS
Diuretics are drugs that increase the excretion of Na+ and water from the
body  by  an  action  on  the  kidney.  Their  primary  effect  is  to  increase  the
reabsorption  of  Na+ &  CI- from  the  filtrate,  increased  water  loss  being
secondary to the increased excretion of NaCl. This can be achieved by
• A direct action on the cells of the nephron.
• Indirectly modifiying the content of the filtrate.
Since a very large proportion of the NaCl and water that passes into the
tubule ion the glomerulus is reabsorbed, a small increase in reabsorption can
result in a marked increase in excretion.
4.1 Loop Diuretics
Example: Furosemide
There is an increase in the excretion of Ca+2 & Mg+2 and a decreased excretion
of uric acid. The effect on Na+ is beneficial in the treatment of hypocalcaemia.
(Rang H. P & Dale M.M., 2003).
4.2 Thiazide Diuretics
Thiazides  increase magnesium excretion,  but  (unlike  many diuretics)
they decrease  calcium excretion in  the  urine.  The hypocalciuria  induced by
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thiazides  appears  to  result  from  decreased  expression  of  calcium  transport
proteins,  including  the  epithelial  calcium channel,  calbindin  and the  Na-Ca
exchanger  protein,  in  renal  tubules.  The  ability  of  thiazides  to  reduce  Ca+2
excretion is the basis for their use in the treatment of kidney stones caused by
excessive calcium in the urine. (George H. Brenner., 2010).
4.3  Inducing Agents of Diuretic & Saluretic activity
In vitro methods (Gerhard Vogel H., 2002)
• Carbonic anhydrase inbition
• Patch clamp technique in kidney stones
• Perfusion of isolated kidney tubules
• Isolated kidney
In vivo methods
• Diuretic activity in rats (Lipschitz test)
• Saluretic activity in rats
• Diuretic and Saluretic activity in dogs
• Clearence methods
• Micropuncture techniques in rats
• Stop flow technique
Today, medicinal plants are very important for the growth of new drugs.
People  are  using  herbal  drug because of  its  safety,  efficacy and  lesser  side
effects. Plants and plant products have utilized with varying success to cure and
prevent  diseases.  At  present  demand of  natural  plants  derived  products  are
increasing day by day in global countries. The significance of medicinal plants
in national economy and its potential for the rapid growth of herbal products
have been emphasizing frequently ( Ankur et al.,2010).
       The plant kingdom plays an  important role in the life of humans and
animals. India is the largest producer of medicinal plants and is rightly called as
"Botanical  garden of the world". Medicinal plants have stated to compromise
about 8000 species and account for approximately about 50 %of all the higher
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flowering plant species of India. In other words there are about 400 families of
the flowering plants; atleast 315 are represented by India. In recent years, the
use of traditional medicine information on plant research has again received
considerable interest. The western use of such information has also come under
increasing scrutiny and the national and indigenous rights on these resources
have  become  acknowledged  by  most  academic  and  industrial  researchers.
(Govind Pandey at al., 2010).
The plant Clitoria ternatea is commonly known as butterfly pea is an
important medicinal plant belonging to Fabaceae family .Clitoria ternatea is a
herbaceous plant  grows as vine or creeper and flourishes most of  the moist
neutral soil. Flowers are solitary having blue or white colours . 
Clitoria ternatea is grown as ornamental plant. In South East Asia the
flowers of this pea vine are used as an ingredient  to colour food item. The
young or tender beans (Seed pods) are edible and are used in various medicinal
preparations.
The  juice  of  flower  is  reported  to  be  used  in  insect  bite  and  skin
diseases.  The  roots  are  useful  asthma,  burning  sensation,  ascites,  and
inflammation.  The  entire  herb  is  used  its  action on  the  CNS especially for
boosting memory and improving intellect. The extract of the plant is used as an
ingredient in Medhya- Rasayana is juvenating recipe used for the treatment of
neurological disorders. The plant is considered to be good brain tonic and is
useful  for  throat  and  eye  infection,  skin  diseases,  urinary  troubles.  Further
aqueous extract of leaves have diuretic and urinary bladder diseases. 
CHAPTER- II
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LITERATURE REVIEW
Harbrone et.al (2000)
Antioxidants  act  as  radical  scavengers,  inhibit  lipid  peroxidation  and
other  free radical-mediated processes,  and therefore they protect  the human
body  from  several  diseases  attributed  to  the  reactions  of  radicals.  Various
phenolic antioxidants such as flavonoids, tannins, coumarins, xanthenes and,
more recently, procyanidins have been shown to scavenge radicals in a dose-
dependent manner and therefore are viewed as promising therapeutic drugs for
free radical pathologies. Phenolic compounds are a large and diverse group of
phytochemicals, which includes many different families of aromatic secondary
metabolites in plants.  They are known to exert various physiological effects in
humans, such as inhibiting platelet aggregation, reducing the risk of coronary
heart disease and cancer and preventing oxidative damage of lipid and low-
density  lipoprotein.  Phenolic  compounds  have  strong  in  vitro  and  in  vivo
antioxidant  activities  associated  with  their  ability to  scavenge  free  radicals,
break radical chain reactions and chelate metals.
 Many  plant  phenolics  exhibiting  antioxidant  properties  have  been
studied  and  proposed  for  protection  against  oxidation.  Natural  antioxidants
occur in all  parts of  the plant  (wood, bark,  stems, pods, leaves,  fruit,  roots,
flowers, pollen, and seeds). Flower is an important part of plant which contains
a  great  variety  of  natural  antioxidants,  such  as  phenolic  acids,  flavonoids,
anthocyanin    and    many    other phenolic compounds.
Medicinal  plants  are  considered  as  potential  sources  of  antioxidant
compounds.  There  is  an  increasing  interest  in  the investigation of  naturally
occurring antioxidants from plants. One of the plants that deserve attention is
Clitoria  ternatea.  The  ethanolic  extract  of  Clitoria  ternatea Linn, was
evaluated for its in vitro antioxidant activities by DPPH free radical method.
DPPH (Diphenyl picryl hydrazine) is a free radical at room temperature which
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produces violet colour in ethanol. It is reduced in the presence of an antioxidant
molecule,  giving rise to uncoloured solution.  Ascorbic acid was used as the
standard drug for the determination of the antioxidant activity and the EC50
value of ascorbic acid was found to be 6.1 µg/ml. An increased EC50 value was
observed (36.5µg/ml) for the plant extract when compared with standard drug
ascorbic acid (6.1µg/ml). The extract exhibited potent antioxidant activity with
an EC50 of 36.5µg/ml.
The antioxidant properties of Clitoria ternatea has also being assayed by
using the free radical scavengers Ferric reducing power assay (FRAP), super
oxide  dismutase  (SOD),  Di  phenyl  picrylhydrazyl  (DPPH)  and  total  poly
phenols. The study showed that methanolic extract showed good antioxidant
activity than hexane and chloroform extracts.
Sarumathi K Thanarajan et. Al (2011)
The antioxidant activities of the ethanolic extract of Clitoria ternatea on
acetaminophen (APAP) induced toxicity in rats suggest that the ethanol extract
of  Clitoria ternatea can prevent renal damage from APAP (Acetaminophen)
induced nephrotoxicity in rats and it  is likely to be mediated through active
phytoconstituents and its antioxidant activities .  Acetaminophen (APAP) is a
widely used analgesic and antipyretic drug that is safely employed for a wide
range of treatments Phytoconstituents like 1
 Cycloprop[e]azulene,la,2,3,5,6,7,7a,7b octahydro-l, l, 4, 7 tetramethyl-,
[laR-(laa,7a,7aa,7ba)]  [Synonyms:  Varidiflorene],  Pterocarpin,  6H-
Benzofuro[3,2-c]  [l]  benzopyran,  6a,lla-dihydro-3,9-dimethoxy-,  (6aR-cis)-
[Synonyms: Homopterocarpin], Isoparvifuran, Hexadecanoic acid, ethyl ester,
Myo-lnositol, Propane, 1,1-diethoxy- were identified from ethanolic extract of
Clitoria ternatea by using a gas chromatograph-mass spectrograph (GC MS).
The  antioxidant studies  revealed  that  the  levels  of  renal  SOD  (superoxide
dismutase), CAT (catalase), GSH (reduced glutathione) and GPx (glutathione
peroxidase) in the APAP treated animals increased significantly along with a
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reduced  MDA (malondialdehyde)  content  in  ethanolic  extract  of  Clitoria
ternatea treated groups.
The  white  flowered  leaves  had  higher  content  of  all  the  enzymic
antioxidants analyzed than the blue flower . The enzymatic antioxidant activity
of  Clitoria  ternatea was  analyzed  by  using  goat  liver  slices,  in  both  blue
flowered leaf and white flowered leaf of Clitoria ternatea and H202 was used as
oxidant.
The  total  phenolic  compounds  (TPC)  and  1,  1-dipheny  l-2-
picrylhydrazyl  (DPPH)  scavenging  activity  in  the  flowers  and  leaves  of
Clitoria ternatea has been analysed and the presence of antioxidant activity in
both leaves and flowers showed that Clitoria ternatea have the potential to be
an alternative source of natural antioxidants. It  is concluded that scavenging
activity expressed by Clitoria ternatea flower is affected by the amount of total
phenolic compound.
Jain Sukla et.al.; (2008)
Phytochemical analysis has revealed that the stem contains phytosterols,
phenolic  compound,  flavonoids  and  carbohydrates.  Various  in  vitro models
were applied to evaluate anti oxidant property of these extracts. In vitro studies
included  Free  Radical Scavenging  Capacity  (RSC)  on  DPPH  Radicals,
Scavenging capacity for hydroxyl radicals, (by measuring the degradation of 2
-  deoxyribose  with  OH  radicals  generated  in  Fenton  reaction),  scavenging
capacity for super oxide radicals (NBT reduction assay, Nitro blue Tetrazolium
assay) and Antioxidant using β -Carotene linoleate model system (B-CLAMS).
The  phytoconstituents  responsible  for  antioxidant  activity  were  isolated  by
preparative TLC method. The methanolic extract showed the maximum free
radical scavenging capacity as compared to acetone extract.
Comparative evaluation of  in vitro  antioxidant activity of root of blue
and white flowered varieties of Clitoria ternatea showed that methanol extracts
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of  blue  and  white  flowered  varieties  of  Clitoria  ternatea showed  a  very
powerful  antioxidant  activity  in  DPPH  radical-scavenging  assay.  Methanol
extracts of Clitoria ternatea also showed significant reductive ability as well as
hydroxyl  radical  scavenging  activity.  Methanol  extract  of  white  flowered
variety of  Clitoria  ternatea showed more  significant  antioxidant  activity as
compared to blue flowered variety of Clitoria ternatea.
Kaisoon Osiramornpun et.al (2004) 
The phenolic compounds and antioxidant capacities of free and bound
phenolics  from  12  available  The  edible  flowers  which  have  long  been
consumed  as  vegetable  and  used  as  ingredients  in  cooking,  has  been
investigated, Clitoria ternatea was one of them. Major phenolic acids identified
in  these  analyses  were  gallic  acid,  ferulic  acid  and  sinapic  acid,  while
predominant flavonoids were quercetin and rutin. The soluble as well as bound
fractions  of  edible  flowers  are  rich  sources  of  phenolic  compounds  with
antioxidant,  DPPH  radical-scavenging  activity  and  reducing  power.  DPPH
radical scavenging capacity of bound phenolic fraction was found to be 17.6%
in  Clitoria  ternatea,  this  suggests  that  screening  edible  flowers as  potential
sources of bioactive components with high antioxidant properties may be of
interest to consumers and public health workers.
A polyherbal  formulation  (Rheumatone)  made  using  five  medicinal
plants  namely  Clitoria  ternatea,  Sida  cordifolia,  Cleodendron  serratum,
Bacopa  monnieri,  Cardiospermum  Halicacabum,  does  not  exhibit  any  side
effects and it has the enzymatic antioxidant activity. There was a significant
reduction in the levels of Super oxide dismutase (SOD), Catalase, Peroxidase
and Glutathione peroxidase (GPx) in the liver and kidney of adjuvant induced
arthritic  rats  and  there  was  an  elevated  level  of  Super  oxide  dismutase,
Catalase, Peroxidase noted in the Liver and Kidney of rats that were treated
with  the  polyherbal  formulation  Rheumatone  compared  with  the  toxic  rats.
There was a significant increase of Glutathione peroxidase in Liver and Kidney
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of  rats  treated  with  Rheumatone  compared  with  Group  II  rats  treated  with
Freund's Complete Adjuvant (FCA).
Jayaka .B. Suresh et.al., (2003) 
Diabetes mellitus is a syndrome characterized by chronic hyperglycemia
and disturbances of carbohydrate, fat and protein metabolism associated with
absolute or relative deficiency in insulin secretion or insulin action. Diabetes
mellitus  is  also  associated  with  an  increased  risk  for  developing  premature
atherosclerosis  due to  independent  risk  factors  such  as  hypertriglyceridemia
and hypertension . Insulin therapy and oral hypoglycemic agents offer effective
glycemic control; yet, their shortcomings limit their usage. The world health
organization (1980) has also recommended the evaluation of the effectiveness
of plants in conditions where we lack safe modern drugs water law M.E.Wang
(2002) states that Phytochemicals isolated from plant sources are used for the
prevention and treatment of cancer, heart disease, diabetes mellitus and high
blood pressure. Plants are reputed in the indigenous systems of medicine for
the treatment of various diseases, the available literature shows that there are
more  than  800  plant  species  showing  hypoglycemic  activity  and  Clitoria
ternatea is one of them.
Chronic administration of plant extracts (100mg/kg) for 14 days reduces
the blood glucose level of the diabetes induced animals (Wistar Albino rats) as
compared to diabetic control group. There was significant decrease in the blood
glucose  level  in  the  7th  and  14th  days  of  the  diabetes  induction,  showing
antidiabetic effect. The effect was comparable to that of standard antidiabetic
drug Glibenclamide. Hyperglycemia was induced by intra peritoneal injection
of  freshly  prepared  aqueous  solution  of  alloxan monohydrate.  Extensive
damage to theislets of langerhans and reduced dimensions ofislets were found
in control animals. Restoration of normal cellular populatation and size of islets
with hyperplasia were seen in extract treated groups. The partial restoration of
normal cellular population and enlarged size of β-cells with hyperplasia were
indicative of the antidiabetic potential of the plant. Aqueous extracts of Clitoria
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ternatea plant  showed anti-  hyperglycemic  activity in  streptozotocin  treated
rats  and  this  effect  is  because  of  increase  in  glucose  uptake  and  glycogen
deposition in isolated rat hemi diaphragm
Daisy P & Rajashi et.al. (2009)
Clitoria  ternatea leaf  and  flower  extracts  exhibit  antihyperglycaemic
effect  in  rats  with  alloxan-induced  diabetes  mellitus.  The  effect  of  orally
administered aqueous extracts (400 mg/kg body weight) of  Clitoria ternatea
leaves and flowers on serum glucose, glycosylated haemoglobin, and insulin
were  examined  in  control  and  extract-treated  diabetic  rats.  The  aqueous
extracts of  Clitoria ternatea leaves and flowers significantly reduced serum
glucose,  glycosylated  haemoglobin  and  the  activities  of  gluconeogenic
enzyme, glucose-6- phosphatase, but increased serum insulin, liver and skeletal
muscle glycogen and the activity of the glycolytic enzyme, glucokinase. For all
the biochemical tests performed, the leaf extract-treated rat showed essentially
the same profile as those treated with the flower extract.
The alcoholic root  extract  of  Clitoria  ternatea has  shown significant
gross  impact  in  preventing  the  possible  complications  related  to  brain
hippocampal  area  CA3  and  pancreatic  tissue  in  juvenile  diabetic  rat
experimental models . These benefits could be due to interference of number of
chemical  compounds  present  in  this  extract.  Encephalopathy  is  a  major
complication  in  juvenile  diabetes  mellitus  which  cripples  the  potential
physiomorphological growth and development in early childhood. It  is  very
essential to diagnose and initiate the treatment at the earliest to prevent the
possible  complications.  The  ancient  medical  science  Ayurveda  mentions
number of remedies to treat cognitive dysfunctions, the herbal root of Clitoria
ternatea plant is one among them.      
Kavitha & Prema Lekshmi et.al., (2004)
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Clitoria  ternatea leaf  extract  shows  the  synergetic  effect  along  with
Trichosanthes  dioica  leaf  extract on the  Streptozotocin-induced  diabetic  rat.
The ethanolic extracts of  Trichosanthes dioica leaf and  Clitoria ternatea leaf
exhibited  higher  degree  of  antihyperglycaemic  activity.  With  regard  to  the
mechanisms, it cannot be excluded that  Trichosanthes dioica leaf extract and
Clitoria  ternatea leaf  extract  may  contain  some  biomolecules  that  may
synthesize the insulin receptor to insulin or stimulate the beta cells of islets of
Langerhans  to  release  insulin  which  may  finally  lead  to improvement  of
carbohydrate  metabolizing  enzymes  towards  the  establishment  of  normal
glucose levels.  Significant  and higher degree of antihyperglycaemic efficacy
was  reviewed with combination (200 mg/kg of Trichosanthes dioica leaf  200
mg/kg of  Clitoria ternatea leaf) when compared to the extent of efficacy that
was obtained with 400 mg/kg dose of individual plant extracts of Trichosanthes
dioica leaf and Clitoria ternatea leaf.
HEPATOPROTECTIVE POTENTIAL OF Clitoria ternatea
Despite  remarkable  advances  in  modern  medicine,  hepatic  disease
remains a worldwide health problem, thus the search for new medicines is still
ongoing. Hepatic cells participate in a variety of metabolic activities; therefore
the development of liver protective agents is of paramount importance in the
protection  from  liver  damage.  The  literature  has  constantly  shown  that
hepatoprotective effects are associated with plant extracts rich in antioxidants.
Many  compounds  and  extracts  from  plants  have  thus  been  evaluated  for
hepatoprotective  and  antioxidant  effects  against  chemically-induced  liver
damage.  Many  studies  have  been  done  on  the  hepatoprotective  activity  of
Clitoria ternatea.
Somania R Vadnala et.al (2011)
Ethanolic  extract  of  leaves  of  Clitoria  ternatea (EECT,  200  and  
400mg/kg)  was  evaluated  for  prophylactic  and  therapeutic  hepatoprotective
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activity against  carbon tetrachloride induced hepatic damage Silymarin  (100
mg/kg)  was  used  as  standard  drug.  Hepatoprotective  effect  of  EECT  was
evident in prophylactic and therapeutic groups at doses of 200 and 400 mg/kg.
Histopathology of liver ascertained the effect of EECT and carbon tetrachloride
on cytoarchitecture of the liver. The liver section of normal control  animals
indicated the presence of normal hepatic parenchyma, whereas administration
of carbon tetrachloride in animals showed severe centrilobular necrosis, fatty
changes, vacuolization and ballooning degeneration indicating severe damage
of  liver  cytoarchitecture.  The  EECT  200  mg/kg  in  both  prophylactic  and
therapeutic  studies  showed  recovery  and  protection  from  hepatocyte
degeneration,  centrilobular  necrosis,  fatty  infiltration,  whereas  EECT  400
mg/kg  showed  mild  to  normal  cytoarchitecture  that  indicated  the  dose
dependent hepatoprotection of  EECT. The silymarin treated animals showed
slightly altered hepatic parenchyma and uniform spread sheets of hepatocytes
which  indicated  functional  liver,  on  account  of  regenerative  activity.  The
possible  prophylactic  and  therapeutic  hepatoprotective  effect  of  Clitoria
ternatea leaves  was  attributed  due  to  the  presence  of  flavonoids  which
contributed to its antioxidant property. 
Palil et.al., (2011) 
Methanolic  extracts  of  blue  and  white  flowered  varieties  of Clitoria
ternatea have  potent  hepatoprotective  action  against  carbon  tetrachloride
induced hepatic damage in rats . Methanol extract of white flowered variety
(MEWFV)  effectively  control  SGOT  (serum  glutamate  oxaloacetate
transaminase),  SGPT  (serum  glutamate  pyruvate  transaminase)  and  ALP
(serum alkaline phosphatase) as compared to methanol extract of blue flowered
variety  (MEBFV).  MEWFV  of  Clitoria  ternatea showed  more  significant
hepatoprotective  activity  as  compared  to  MEBFV of  Clitoria  ternatea. The
possible  mechanism of  this  activity was due  to  free  radical-scavenging and
45
antioxidant activity, which may be due to the presence of phenolic compounds
in the extracts. 
Barik D.P.Naiks et.al
The hepatoprotective effect against paracetamol-induced liver toxicity in
mice  of  ME  (Methanol  Extract)  of  Clitoria  ternatea leaf  was
studied  by monitoring the levels of Aspartate aminotransferase (AST), 
Alanine  aminotransferase  (ALT)  and  billirubin  along  with  histopathological
analysis. The mice treated with the ME of  Clitoria ternatea leaf (200 mg/kg)
showed a significant decrease in ALT, AST, and bilirubin levels, which were all
elevated in the paracetamol group; this confirmed the hepatoprotective effect of
Clitoria ternatea leaf extract against the model hepatotoxicant paracetamol. The
hepatoprotective action was likely related to its potent antioxidative actjyity.
Narayana Swamy & K.Selvi et.al.,(2005)
A polyherbal formulation named "Ayush-Liv.04" consisting of  Clitoria
ternatea leaves  20%  as  one  of  its  constituents  was  evaluated  for  its
hepatoprotective  activity against  ethanol  and CCI4 induced liver  damage in
rats. The activities of liver marker 'enzymes in serum namely AST (Aspartate
aminotransferase),  ALT  (Alanine  aminotransferase),  ALP  (Serum  alkaline
Phosphatase), ACP( Serum acid Phosphatase) and serum bilirubin level (total)
were increased in toxic group animals. But the activities of these enzymes were
significantly  lowered  in  post-treated  group  of  rats.  This  suggests
antihepatotoxicity of "Ayush-Liv.04".
A.D.Taranalii  and  T.C.  Cheeramkuzhi(2000) says  that  Clitoria
ternatea extracts increases the memory and central cholinergic activity in rats.
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III. SCOPE OF WORK
There  are  several  options  available  in  the  management  of  ureteral
stones. Treatment selection depends on stone size, location and composition,
efficacy  of  each  modality  and  associated  morbidity,  equipment  available,
physician skill, patient health and preference and finally costs. In many cases,
the  management  of  urolithiasis  is  combined  surgical  and  medical  approach
using  percutaneous  nephrolithotomy  (PCNL),  extracorporeal  shock  wave
lithotripsy (ESWL) and antibiotics.
          These treatments are relatively costly, painful and require expert hands
and availability of appropriate equipments. This has given rise to stimulation in
the search for investigating natural resources showing antiurolithiatic activity.
In  spite  of  tremendous advances  in  the  field  of  medicine,  there  is  no  truly
satisfactory drug for the treatment of renal calculi. Most patients still have to
undergo  surgery to  be  rid  of  this  painful  disease.  Ayurveda,  an  indigenous
system of Indian medicine, offers vast scope for the successful  treatment of
urolithiasis.
          Plants and other natural substances have been used as the rich source of
medicine. All ancient civilizations have documented medicinal uses of plant in
their own ethnobotanical texts. The list of drugs obtained from plant source is
fairly extensive. Many remedies have been employed during the ages to treat
urolithiasis.  Most of  the remedies were taken from plants and proved to be
useful,  though the rationale behind their  use is not  scientifically established
except for a few plants and some proprietary composite herbal drugs.
The traditional system of Indian medicinal plants recommends several
plants for the treatment of lithiasis, in this background; we decided to evaluate
the antilithiatic and diuretic potential  Clitoria ternatea (L)  leaves  which is
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commonly  used  as  a  folk  medicine  for  lithiasis  and  also  for  its  diuretic
potential.
The literature survey revealed that there are no scientific studies carried
out regarding antilithiatic and diuretic activity on the liquid extract  Clitoria
ternatea (L) , hence in the present study the aqueous leaves extract Clitoria (L)
leaves was examined for its antilithiatic & Diuretic property.
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PLAN OF WORK
The present study was designed with the following steps in order to assess
the antilithiatic activity and diuretic potential of  Clitoria ternatea         
 Collection
 Extraction
 Identification of AECT(Aqueous extract of Clitoria ternatea).
 Evaluation  of antilithiatic activity
a. Selection of animals
b. Induction of lithiasis
c. Experimental design
d. Assessment of Antilithiatic activity
 Evaluation of Diuretic activity
a. Selection of animals
b. Experimental design
c. Assessment of Diuretic activity.
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IV. PLANT PROFILE
  
Figure 4: Clitoria ternatea L.
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Figure 5: Clitoria ternatea L.
Botanical classification
 Kingdom                  plantae
 Subkingdom            angiospermae
 Division                   eudicots
 Class                        rosids
 Order                       fabales
 Family                     fabaceae
 Genus                      clitoria
 Species                     ternata
Vernacular names
 Common name: butterfly pea,blue pea,cordan pea.
• English             Butterfly pea
• Brazil:              Cunha.
• Sanskrit            abragitha, krikarnika
• Telugu              klakarnika
• Kannada           sangu puspha
• Malayalam       kakkattan
• Tamil                sangu pusphapam
CHAPTER IV
INTRODUCTION
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Clitoria  ternatea (Family-•Fabaceae,  previously  known  as
Papillioneceae), a perennial twining herb, stems terete, more or less pubscent.
Leaves imperipinnate, petioles 2-2.5 cm long; stipules 4 mm long, linear, acute.
Leaflets 5-7, subcoriaceous, 2.5-5 by 2-3.2 cm, elliptic-oblong, obtuse or caute;
stipules  filiform..Flowers-  axillary,  solitary,  standard  bright  or  blue  or
sometimes white, with an orange centre; seed- 6-10, yellowish brown, smooth.
Two  types-  white  variety  and  blue  flowered  variety;  widely  distributed
throughout Bangladesh, used as ornamental plant 
Distribution
Originated from tropical Asia and later was distributed widely in South
and  Central  America,  East  and  West  Indies,  China  and  India,  where  it  has
become naturalized. Native to the island of Ternate in the Molluca archipelago,
this species is now widely grown as ornamental, fodder or medicinal plant. It is
found commonly as an escape in hedges and thickets throughout India to an
altitude of 15cm and in Andaman Islands It can be grown as a forage legume
either  alone  or  with  perennial  fodder  grasses  in Punjab,  Rajasthan,  Uttar
Pradesh,  Gujarat,  Maharashtra,  Madhya-Pradesh,  Andhra-Pradesh  and
Karnataka. The plant is also suitable as a green manure and cover crop. Besides
suppressing  many perennial  weeds,  it  enriches  the  soil  by  fixing  nitrogen.
Clitoria  ternatea is  now widely distributed throughout  the humid,  low land
tropics, occurring both naturally and in cultivations .
Clitoria  ternatea is  now  widely  distributed  throughout  the  humid,
lowland tropics occurring both naturally and in cultivations.
Cultivation
 Clitoria ternatea is a deep-rooted, tall slender, climbing legume with
five leaflets and a deep blue flower. It is well adapted to a variety of soil types
(pH 5.5-8.9) including calcareous soils.  It  is  surviving in both the extended
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rainfall regions and prolonged periods of drought. Propagation is done through
seed. It exhibits excellent re-growth after cutting or grazing within short period
and produce  high  yields  also.  Clitoria  ternatea L is  well  adapted  to  heavy
cracking clay soils in northern Australia.
It  is  also  used  as  a  cover  crop  and  green  manure.  The  seeds  are
normally sown from the beginning until  the middle of the wet season.  It
persists best when grazed lightly during the wet season .
Chemical constituent 
Ethanol  extract  of  Clitoria  ternatea shows  presence  of  terpenoid,
flavonoid, tannin and steroid which may act as antioxidant principal. The major
phytoconstituents found in  Clitoria ternotea  are the pentacyclic triterpenoids
such as taraxerol and taraxerone. Phytochemical screening of the roots shows
the  presence  of  ternatins,  alkaloids,  flavonoids,  saponins,  tannins,
carbohydrates, proteins, resins, starch, taraxerol and taraxerone.
A wide range of secondary metabolites including triterpenoids, flavones
glycosides, anthocyanins and steroids has been isolated from Clitoria ternatea
Linn. Four kaempferol glycosides I, II, III and IV were isolated from the leaves
of  Clitoria ternatea  L. Kaempferol-3-glucoside (I),  kaempferol- 3- rutinoside
(II) and kaempferol-3- neohesperidoside (III) were identified by Ultra Violet,
Protein Magnetic Resonance and Mass Spectrometry. (IV), C33H40O19, mp:
198, was characterized as Kaempferol-3- orhamnosyl glucoside from spectral
data and was named clitorin 
The seeds contain nucleoprotein with its amino-acid sequence similar to
insulin,  delphinidin-3,3,5-triglucoside,  essential  amino-acids,  pentosan,
watersoluble mucilage, adenosine, an anthoxanthin glucoside, greenish yellow
fixed oil, a phenol glycoside, 3, 5, 7, 4-tetrahydroxy-flavone-3-rhamoglycoside,
an alkaloid, ethyl D-galactopyranoside, p-hydroxycinnamic acid polypeptide, a
highly basic protein-finotin, a bitter acid resin, tannic acid, 6% ash and a toxic
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alkaloid.  Seeds  contain  sitosterol,  β-sitosterol,  and  hexacosanol  and
anthocyanin glucoside.
It  also  contains  anti-fungal  proteins  and  has  been  shown  to  be
homologous to plant defensins.Aabgeena et al. reported a lectin present in the
seeds of  Clitoria ternatea agglutinated trypsin-treated human B erythrocytes.
Since the purified lectin was found to be potential tool for cancer studies so an
attempt  was  made  for  the  alternate  high  yielding  purification  method  for
Clitoria ternatea lectin designated CTL, present in the seeds of this member of
fabaceae family.
Recent   study  showed  that  malonylated  flavonol  glycosides  were
isolated from the petals of  Clitoria ternatea with different petal colors using
LC/MS/MS. It was also reported that five new anthocyanins, ternatins A3, B3,
B4, B2 and D2 were isolated from  Clitoria ternatea flowers,Kaempferol-3-
glucoside,kaempferol-3-robinobiosiderhamnoside,  quercetin  and  quercetin  3-
glucoside. Six ternatins Al, A2, Bl, B2, Dl and D2 in Clitoria ternatea flowers
were isolated by reversed phase High Performance Liquid Chromatography
and their structures were partly characterized as highly acylated delphinidin
derivatives.  Clitoria ternatea was powdered and evaluated quantitatively for
the analysis of total soluble sugars, protein, phenol, starch, carbohydrate and
lipid .
Leaves 
Leaves contain 3 monoglucoside, 3-rutinoside, 3 neohisperidoside, 3- o-
rhamnosyl Glycoside, kaempferol- 3- o-rhamnosyl, aparajitin, beta-sitosterol,
and essential oil.
Flower
 Flower  contains  delphinidin-3,  5-diglucoside,  delphinidin-3,  
5-glucoside, and malvidin- 3β - glucoside, kaemphferol, p-coumaric acid.
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Root 
Contains  β-  carotene,  stigmast-  4-  ene-  3,  6  diene,  taraxerol  &
teraxerone, starch, tannins & resirvs
Toxicity
 Ethanol extract did not show any sign of toxicity upto 2000mg/kg dose .
Pharmacology
• Seeds are cathartic and the root diuretic.
Flower: Ethanol extract is used as antidiabetic.
Anxiolytic Activities
 In  study,  the  effect  of  alcoholic  extract  of  aerial  parts  of  Clitoria
ternatea on  spatial  discrimination  in  rats  followed  by  oral  treatment  with
alcoholic extract at a dose of 460 mg/kg significantly prolonged the time taken
to  traverse  the  maze,  which  was  equivalent  to  that  produced  by
chlorpromazine.
The oral  administration of  Clitoria  (100-400mg/kg) dose dependently
increased the time spent in the open arm; the time spent in the lit  box and
decreased the duration of time spent in the dark box. The oral administration of
Clitoria ternatea (30mg/kg) failed to show any significant effect in both animal
models  of  anxiety.  The  animals  treated  with  Clitoria  ternatea (lOOmg/kg)
showed a significant increase in the inflexion ratio and discrimination index
which providesevidence for the species nootropic activity .
CNS Depressant Activity Studies
The Clitoria ternatea extract was found to possess nootropic, anxiolytic,
antidepressant  and  anti-stress  activities.  The  nootropic  drugs  facilitate
intellectual performance, learning and memory.
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Anti-Stress Activities of Clitoria ternatea 
The anti-stress activity of aerial parts was assessed using cold restraint
stress (CRS) induced ulcers, lithium-induced head twitches, clonidine-induced
hypothermia, sodium nitrite-induced respiratory arrest and haloperidol-induced
catalepsy in rat and mice 
Effect of Clitoria ternatea on general behavior
Ethanol  extract  of  the  root  of  Clitoria  ternatea shows  significant
neuropharmacological activity 
Immunomodulatory Effects 
The plant extracts have immunomodulatory effects that strengthen the
immune system.
Larvicidal Activities
 The methanol extracts of  Clitoria ternatea seed extract was effective
against the larvae of all the three species with LC50 values 65.2, 154.5 and
54.4  ppm,  respectively  for  A.stephensi,  A.aegypti and  C.quinquefascitus.
Clitoria ternatea was showing the most promising mosquito larvicidal activity .
Proteolytic Activities
 The  activities  of  endopeptidases  (hemoglobin    pH    3.5    and
azocasein   pH 6.0),  carboxypeptidase benzyloxy carbonyl (CBZ-Phe-Ala Ph
5.2),  and arylamidases  lysophosphatidic  acid  and a-N-benzoyl-L-arginine P-
nitro-analide (LPA 7.0 and BAPA 7.6) were assayed in extracts of cotyledons
and  axis  of  resting  and  germinating  seeds  of  Clitoria  ternatea but  the
endopeptidases at pH 3.5 and the arylamidase at 7.0 were high in cotyledons.
The activities of carboxypeptidase and the arylamidase increased in cotyledons
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reaching a maximum at the day 9, while the endopeptidases showed an increase
at the day 3 followed by a decrease. In the axial tissue the endopeptidases and
carboxypeptidase activities showed an increase until the day 9 followed by a
decrease and arylamidase were low. The increase of acidic endopeptidases and
carboxypeptidase activities in germinating cotyledons is an indication of their
participation in the degradation of the storage proteins
Antihelmintic Activities:
             There are so many studies which have been reported on antihelmintic
activity of  Clitoria ternatea.  It  was indicated that crude alcoholic extract of
Clitoria  ternatea and  its  ethyl  acetate  and  methanol  fractions  significantly
demonstrated paralysis  and also caused death of  worms especially at higher
concentration  of  50  mg/ml,  as  compared  to  standard  reference  piperazine
citrate. Inhibitory effect of  Clitoria ternatea leaves on free-living nematodes
was evaluated using aqueous and methanol extract. In another study, flowers,
leaves, stems and roots of  Clitoria ternatea were evaluated for antihelmintic
activity on adult Indian earthworms Pheretima posthuma.  Methanol extract of
root is most potent and required very less time to paralysis and death of worms
as  compared  to  other  extracts.  The  potency increases  from flowers,  leaves,
stems to roots .
Diuretic Activity
 The  powdered form of  dried  whole  root  and  ethanolic  extract  were
evaluated  for  diuretic  activity  and  only single  I.V.  dose  of  extract  produce
moderate  increase in  urinary excretion of  Na,  K and decrease  in CI but no
change in urine volume. Also, an appreciable effect was seen on oral dosing
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CHAPTER V
V. MATERIALS AND METHODS
Plant materials
The  leaves  of  Clitoria  ternatea was  collected  was  collected  from
kaniyakumari  district  in  the  month  of  July.  Then  washed  then  dried  at  70
degree C .Then the leaves are powered and then stored in air tight container.
Drugs and chemicals.
Cystone and ethylene glycol purchased from commercial sources and all
other chemicals were of analytical grade.
PREPARATION AQUEOUS EXTRACT
Powdered leaves of  Clitoria ternatea 1500gm was kept for maceration
with 2000ml of water for 24hours during successive extraction. The extract was
double  filtered  using  muslin  cloth  and  Whatmann  filter  paper  No:1and  the
extract concentrated and dried on water bath. The different concentration of
aqueous extract were prepared for further study.(S.Singh et.al) 
Phytochemical tests for active constituents
Identification of alkaloids 
• Mayer’s reagent :  to one ml of the solution add Mayer’s reagent
(potassium mercuric chloride)—yellow precipitate was formed.
• Wagner’s reagent :to one ml of the aqueous extract add one ml
of  Wagner’s  reagent  (aqueous  iodine  solution)__a  brown
precipitate was formed.
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Identification of glycoside 
Keller killiani reaction
The dried substance was dissolved in glacial acetic acid and treat with one or
two drops of ferric chloride and concentrated sulphuric acid was added. The
upper layer produces green colour.
Identification of trepenoid and steroid.
To  5ml  of  the  plant  extract  0.5ml  of  acetic  anhydride  and  0.5ml  of
chloroform  was  added.  Then  concentrated  solution  of  sulphuric  acid  was
slowly  and  red  violet  colour  was  observed  for  terpenoid  and  green  bluish
colour for steroid.
Test for saponins
To test the presence of saponins frothing test was done. To the extract
water was added and on warming frothing showed the presence of saponins.
Test for tannins
Approximately 5g of each portion of the extract was stirred with 10ml of
distilled water on a magnetic stirrer, filtered and ferric chloride reagent added
to the filtrate. A blue black, green or blue- green precipitate indicates for the
presence of tannins.
Tests for flavonoids
Four milligram of each plant extracts solution was treated with 1.5ml of
50% ethanol solution.  The solution was warmed and metal  magnesium was
added. To this solution, 5-6 drops of concentrated hydrochloric acid was added
and red colour was observed for flavonoids and orange colour for flavones.
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CHAPTER VI
EVALUATION OF ANTILITHIATIC ACTIVITY
Experimental Animals
Male albino wistar rats weighing between 150-200gm were used. The
animals were fed with commercial rat feed pellets (Amrut laboratory animal
feed Ltd. Sangli, India) and were given water ad libitum. They were housed in
polypropylene cages under proper humidity conditions (temperature: 25 ± 2°C)
and maintained on normal 12-12 h day-night cycle. The experimental protocol
and all the procedures were approved by Institutional animal ethical committee
(IAEC) of Ultra College of Pharmacy (UCP/IAEC/2010/54).
Ethylene glycol induced urolithiasis model
While  there  are  several  animal  models  that  are  used  to  study
hyperoxaluria  and  its  consequences,  the  most  commonly  employed  and
simplest approach to induce hyperoxaluria is to provide ethylene glycol (EG) in
an animal's drinking water ( Green L.M, et al.,2005)
Ethylene glycol (0.75%v/v) induced hyperoxaluria model was used to
assess the antilithiatic activity in albino rat.  Ethylene glycol was prepared in
water (0.75% v/v) and stored in bottles before commencement of treatment.
Ethylene  glycol  is  reported  to  be  renotoxic,  urine  parameters  were
estimated at the end of study to assess kidney functions. Ethylene glycol major
toxicities  are  as  a  result  of  it  being  metabolized  to  oxic  metabolite  by  an
enzyme alcohol dehydrogenase (Hadjzadeh M. A. R et al., 2008)
Ethylene  glycol  is  readily  absorbed  along  the  intestine  and  is
metabolized in the liver to oxalate. When ethylene glycol is metabolized by
the body it produces four toxic metabolites, they are glycoldehyde, glycolate,
glycolic  acid  and  glycoxalate.  These  metabolite  causes  tissue  destruction
primarily from calcium oxalate crystal deposition. Oxalic acid combines with
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calcium  to  form  calcium  oxalate  crystals,  which  deposits  in  the  kidney
(Schaldt L et al., 1998).
Experimental Design
Animals were divided into five groups containing three animals in each
group.  Lithiasis  was  induced  by  the  administration  of  0.75%  ethylene
glycolated water to all groups viz., Lithiatic, standard and test groups except
the normal control for 28 days. The lithiatic group were not received any drug.
The standard group was received antiurothiatic drug cystone (750 mg/kg) from
15th day and  test  groups  were  maintained  in  two  regimens  as  curative  and
preventive.  In  curative  regimen  the  aqueous  extracts  of  leaves  of  Clitoria
ternatea was administered from 15th day and in preventive regimen the aqueous
extract of  Clitoria ternatea was given from lsl day onwards. All groups were
maintaining on commercial pellet diet for 28 day (Karadi et al., 2006).
ASSESSMENT OF ANTIUROLITHIATIC ACTIVITY
Collection and Analysis of Urine
On 14th and 28th day all animals were kept in individual metabolic cages
and urine samples were collected for 24hrs in measuring cylinder. During urine
collection the  animals  were  free  access  of  normal  water  but  not  food.  The
collected  urine  sample  was  analyzed  for  calcium,  magnesium,  oxalate,
creatinine and phosphate using standard methods. The urinary volume of all
groups were also noted ( Christina et al., 2005) Calcium and magnesium were
determined by colorimetric method; oxalate was determined by Hodgkinson
and William's method, Phosphate using Fiske and subbarow method.
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Microscopic Examination of Urine
For microscopy, 1 ml of the fresh urine sample was centrifuged at 3,000
rpm (revolutions per minute) for 10 minutes, and then 950pl of the supernatant
was discarded. The crystals were identified by light electron microscope. (Jie
Fan, 1999)
Serum Analysis
After the experimental period, animals will be anaesthetized with diethyl
ether.  Blood was  collected from the tail  vein  in  non  heparinized  tubes  and
centrifuged  at  2000  rpm  for  20  min  to  obtain  serum  and  is  analysed  for
creatinine, BUN (blood urea nitrogen), and uric acid  (Atef M Al-Attar, 2010
EVALUATION OF DIURETIC ACTIVITY
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Experimental Design
Male albino wistar rats weighing between 150-200gm were used. The
animals were grouped into four of three animals each and they were fasted and
deprived of food and water for 18 hours prior to the experiment. The first group
received only 0.9% Nacl solution 25 ml/kg, p.o. The second group served as
the standard group, received the standard drug furosemide 20 mg/kg ,p.o . Rest
of the two groups received aqueous extract of leaves of  Clitoria ternatea  of
250 mg/kg and 500 mg/kg suspended in 0.9% Nacl solution.
All  the  animals  received  priming  dose  of  0.9%  Nacl  solution  
(25 ml/kg, p.o). (Basavaraj C. Koti et al., 2010)
Table :3
Group I
Normal Control
0.9% sodium chloride solution 25ml/kg, p.o.
Group II
Standard
0.9% sodium chloride solution 25 ml/kg, p.o.+ standard drug
Furosemide 20 mg/kg,p.o.
Group III
Dose I
0.9% sodium chloride solution 25 ml/kg,p.o+
Aqueous  extract  of  Clitoria  ternatea(250  mg/kg  body
weight, p.o)
Group IV
Dose II
0.9% sodium chloride solution 25 ml/kg,p.o+
Aqueous  extract  of  Clitoria  ternatea(500mg/kg  body
weight, p.o).
ASSESSMENT OF DIURETIC ACTIVITY
Collection and Analysis of Urine
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After  oral  administration  each  animal  were  placed  in  an  individual
metabolic  cages  specially  designed  to  separate  feces  and  urine  at  room
temperature. The observed parameters were total urine volume for 5 hours. Na+
K+, and CI- excreted in urine.
The concentration of the electrolytes in urine is expressed in terms of
mmol/1  and  the  urine  volume  is  expressed  in  ml/100g/5  hours.  Na+,  K+
concentrations were measured by Flame photometer and Cl- concentration was
estimated by titration with silver nitrate solution (N/50) using three drops of
5% potassium chromate as an indicator (Basavaraj C. Koti et al., 2010).
Statistical Analysis
The results were expressed as mean ± S.D. Difference among data were
determined using one way ANOVA (software) followed by Dunnetts test as per
suitability P < 0.05 was considered as significant, P < 0.01 was considered as
very significant.
CHAPTER VII
RESULTS
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The yield obtained from the aqueous extract of leaves of Clitoria 
ternatea was about 12.3g 
i. Urinary Analysis
In  the  present  study,  chronic  administration  of  0.75% (v/v)  ethylene
glycolated water to male albino rats resulted in hyperoxaluria. On 14th day, the
concentration of oxalate, and phosphate were increased in lithiatic, standard,
and curative regimen when compared to normal. However, the treatment with
aqueous extract  of  Clitoria ternatea in preventive regimen reduced elevated
levels  of  these  ions  significantly  (p  <  0.01)  when  compared  with  lithiatic
control group. Contradictorily, the excretion of magnesium and calcium levels
were reduced in lithiatic, standard and curative regimen but these magnesium
level  were  significantly  increased  (p  <  0.01)  in  preventive  regimen  when
compared  with  lithiatic  control  group,  because  the  standard  and  curative
regimen doses has not received any treatment up to 14th day. (Table No.5)
The  concentrations  of  the  various  ions  in  the  collected  urine  were
investigated and found to fluctuate drastically after the treatment. On 28th day,
the  supplementation  with  standard  (Cystone  750mg/kg)  and  curative  and
preventive  regimen  groups  (Aqueous  Extract  Clitoria  ternatea 500mg/kg)
lowered the elevated levels of calcium, oxalate and phosphate when compared
to lithiatic control group. In both curative and preventive regimens of aqueous
extract  of  Clitoria  ternatea treatment  significantly  decreased  excretion
(p<0.01)  of  calcium,  oxalate,  creatinine  and  phosphate  when  compared  to
lithiatic  control  group,  While  magnesium,  one  of  stone  inhibitor  increased
significantly (p<0.0l) than in lithiatic control.
Urine Microscopy
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The microscopic examination (200X) of urine of calculi induced rats
(Group  II)  showed  abundant,  large  crystals  of  Calcium  oxalate  with
characteristic rectangular shape (Fig. 5 A). The Standard drug Cystone treated
animals showed very less or  almost dissolved small  crystals  (Fig. 5B).  On
curative  treatment,  the  aqueous  extract  of  Clitoria  ternatea showed  better
dissolution of the preformed crystals of Calcium oxalate (Fig. 5C); while, on
preventive treatment, the 
Aqueous extract of Clitoria ternatea showed better prevention of stone
formation along with the dissolution of preformed stones (Fig. 5D).
Serum Analysis
The Serum Uric acid and blood urea nitrogen were markedly increased
in  calculi-induced  animals  while  serum  creatinine  was  slightly  elevated  in
Group  II  indicating  marked  renal  damage.  However,  aqueous  extract  of
Clitoria ternatea treatment in curative (Group IV) and preventive (Group V)
Regimen significantly (p<0.01) lowered the elevated serum levels of creatinine,
uric acid and BUN (Blood Urea Nitrogen). 
Diuretic Activity
Urine  volume  (ml),  urine  pH,  concentration  of  Na+,  K+,  and  CI-
electrolytes (mmol/1) in the urine were recorded. The diuretic index of 5 hr
urine samples were calculated to assess the diuretic potential of aqueous extract
of Clitoria ternatea .
The urinary volume of the standard (Furosemide) and aqueous extract of
Clitoria ternatea (250 mg/kg and 500mg/kg) significantly increased (p<0.01)
when  compared  to  control  group.  The  diuretic  index  (Lipschitz  value)  of
standard drug was 5.14,  the AECT 250mg/kg treatment shown 1.27 and the
AECT 500mg/kg treatment shown
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The sodium, potassium and chloride excretion of AECT treatment at both
doses  (250mg/kg  and  500mg/kg)  significantly  (p<0.01)  increased  when
compared to the control group. The standard drug also increased these ionic
excretion levels significantly. (Table No.6)
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Table.5
Effect of Aqueous Extract of Clitoria ternatea in urinary excretion of ions on 14th day
Group
Water intake
(ml/24h)
Urinary
Volume (ml/
24h)
Urinary pH
Urinary Excretion (mg/dl)
Calcium Magnesium Oxalate Phosphate
G1. (Normal Control) 7.70 ± 0.09 7.67 ± 0.105 6.40 ± 0.06 4.14 ± 0.37 0.94 ± 0.018 0.34 ± 0.027 5.85 ± 0.42
G2. (Lithiatic Control) 15.28 ± 0.33 14.96 ± 0.23 5.82 ± 0.12 3.24 ± 0.07 0.75 ± 0.04 2.82 ± 0.11 8.54 ± 0.50
G3. (Standard Treated) 15.01 ± 0.14 14.82 ± 0.17 5.77 ± 0.07 3.21 ± 0.08 0.75 ± 0.06 2.96± 0.13 8.38 ± 0.33
G4. (Curative Treatment) 15.24 ± 0.28 14.86 ± 0.13 5.79 ± 0.07 3.26 ± 0.15 0.69 ± 0.06 2.72 ± 0.08 8.23 ± 0.27
G5. (Preventive Treatment) 9.36 ± 0.19* 9.12 ± 0.06* 6.63 ± 0.06* 4.62 ± 0.07* 1.95 ± 0.02* 1.23 ± 0.12* 6.24 ± 0.26*
Each value expressed as the mean ± SD (n=3) one- way ANOVA; *-P<0.01 when compared with lithiatic control group.
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The 24 hr calcium concentration in rat's urine on day 14
          The 24 hr magnesium concentration in rat's urine on day 14
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               The 24 hr oxalate concentration in rat's urine on day 14
The 24 hr phosphate concentration in rat's urine on day 14
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Table.6
Effect of Aqueous Extract of Clitoria ternatea urinary excretion of ions on 28th day
Group
Water intake
(ml/24h)
Urinary
Volume (ml/
24h)
Urinary pH
Urinary Excretion (mg/dl)
Calcium Magnesium Oxalate Phosphate
G1. (Normal Control) 7.72 ± 0.10 7.89 ± 0.12 6.42 ± 0.03 4.40 ± 0.59 0.96 ± 0.59 0.34 ± 0.013 5.83 ± 0.39
G2. (Lithiatic Control) 15.62 ± 0.18 14.26 ± 0.17 5.76 ± 0.05 3.02± 0.07 0.55 ± 0.01 3.57 ± 0.01 8.93  ±
0.28
G3. (Standard Treated) 10.24 ± 0.15* 9.82 ± 0.04* 6.54 ± 0.09* 4.55 ± 0.07* 1.28 ± 0.04* 1.32 ± 0.02* 6.68 ± 0.11*
G4. (Curative Treatment) 11.00 ± 0.11* 10.77 ± 0.11* 6.72 ± 0.04* 4.80 ± 0.04* 1.19 ± 0.06* 1.55 ± 0.05* 7.03 ± 0.07*
G5.  (Preventive
Treatment)
10.54 ± 0.20* 10.26 ± 0.20* 6.66± 0.02* 4.65 ± 0.06* 1.52 ± 0.04* 1.41 ± 0.01* 6.86 ± 0.03*
Each  value  expressed  as  the  mean  ±  SD  (n=3)  one-  way  ANOVA;  -P<0.01  when  compared  with  the  normal  group;  
*-p<0.01 hen compared with the lithiatic group.
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The 24 hr phosphate concentration in rat's urine on day 28
The 24 hr calcium concentration in rat's urine on day 28
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The 24 hr magnesium concentration in rat's urine on day 28
The 24hr oxalate concentration in rat's urine on day 28
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Table.7
Effect of Aqueous Extract of Clitoria ternatea in serum parameters of
lithiatic rats.
Serum analysis (mg/d)
Creatinine Uric acid
BUN (Blood urea
nitrogen
Group I 0.75 ± 0.01 1.49 ± 0.07 37.61 ± 0.15
Group II 1.73 ± 0.17 4.29 ± 0.14 48.43 ± 0.54
Group III 0.80 ± 0.01* 1.62 ± 0.03* 38.15 ± 1.02*
Group IV 0.88 ± 0.02* 1.92± 0.02* 40.43 ± 0.66*
Group V 0.82 ± 0.02* 1.79 ± 0.03* 39.48 ± 0.49*
Each value expressed as the mean ± SD (N=6) one – way ANOVA ,
-p<0.01 when compared with the normal group
*-p<0.01 when compared with the lithiatic group
The creatinine in rat's blood on day 28
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The uric acid in rats blood on day 28
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The Blood urea nitrogen (BUN) in rats blood on day 28
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Table.8
Diuretic activity of Effect of Aqueous Extract of Clitoria ternatea 
Water  intake
(ml/100g//5h)
Urine pH
Urinary Excretion (mg/dl)
Na+ K+ Cl-
Diuretic
index
Group I 0.51 ± 0.02 6.03 ± 0.06 56.01 ± 1.53 44.15 ± 1.08 38.17 ± 4.8 -
Group II 2.88 ± 0.16 6.71 ± 0.005 111.46 ± 1.20 72.81 ± 0.14 82.20 + 0.44 5.64
Group III 1.27 ± 0.03* 6.67 ± 0.005* 89.09 ± 1.21* 62.95 ± 1.25* 58.87 ± 0.12* 2.47
Group IV 1.74 ± 0.04* 6.69 ± 0.005* 98.25 ± 0.44* 69. 50 ± 0.65* 61.16  ± 0.63* 3.41
Each value expressed as the mean ± SD(n=3)one-way ANOVA, 
*p<0.01 when compared with the standard group.
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The 5 hr sodium concentration in rat's urine
The 5hr potassium concentration in rat's urine
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The 5 hr chloride concentration in the urine of rats
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MICROSCOPIC STUDIES
5A) Lithiatic Control
5B) Standard
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5C) Curative Regimen
5D) Preventive Regimen
5.Urine Microscopy (200X) of A) Calculi induced (Untreated) group; b)
Cystone treated group; C) Aqueous Extract of  Clitoria ternatea treated group
[CR]; D)  Aqueous Extract of Clitoria ternatea treated group [PR]
CHAPTER VIII
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DISCUSSION
             Urinary lithiasis is generally the result of an imbalance between
inhibitors  &  promoters  in  the  kidneys.  Human  kidney  stones  are  usually
composed of Calcium oxalate crystals (Khan,et al., 2010). Rats are the most
frequently used animals in Calcium oxalate deposition, as the urinary system of
male rats resembles that of humans and earlier studies showed that the amount
of  stone  deposition  in  female  rats  was  significantly  less  (Bahuguna,  et  al.,
2010). The urinary super saturation with stone forming constituents is generally
considered to be one of the causative factors in calculogenesis (Bharathi et al.,
2008).
The aqueous extract of Clitoria ternatea contain triterpinoids glycosides
etc. it is confirmed by chemical identification test. In the present study, on 14th
day the oxalate, phosphate excretion was significantly (P<0.01) decreased in
the  preventive  regimen when compared to  lithiatic  group.  The calcium and
magnesium excretion in the urine was significantly increased in the preventive
group, where as it  decreased in the lithiatic group. Urine volume and water
intake was significantly increased in lithiatic control group when compared to
the  normal  animals,  whereas  it  was  significantly  (p<0.01)  decreased  in  the
preventive  group  Urinary  super  saturation  with  respect  to  stone  forming
constituents  is  generally  considered  to be  one  of  the  causative  factors  in
calculogenesis. Administration of ethylene glycol (0.75%, v/v) to young male
albino rats for 14 day period forms renal calculi composed mainly of calcium
oxalate. The biochemical mechanisms for this process are related to an increase
in the urinary concentration of oxalate. Stone formation in ethylene glycol fed
animals is caused by hyperoxaluria, which causes increased renal retention and
excretion of oxalate (Sathish et al., 2010).
On 28lh day, the oxalate, phosphate excretion was significantly (p<0.01)
decreased  and  the  calcium,  magnesium  excretion  levels  were  significantly
82
(p<0.01) increased in both curative and preventive regimens aqueous extract of
Clitoria ternatea when compared with lithiatic control animals.
Following the induction of lithiasis the water intake, urinary volume and
composition were found to be altered. In our study also the urinary output and
waterintake was markedly increased in lithiatic control rats on day 28, however
the urinary  volumes  of  AECT and  standard  treated  rats  were  significantly
(p<0.01) decreased when compared to that lithiatic group.
In urolithiasis, the glomerular filtration rate (GFR) decreases due to the
obstruction to the outflow of urine by stones in urinary system. Due to this, the
waste  products,  particularly nitrogenous substances  such as  urea,  creatinine,
and uric acid get accumulated in blood (Bahuguna, et al.,  2010). In lithiatic
group, the serum levels of creatinine, uric acid, and blood urea nitrogen were
elevated,  while  in  curative  and  preventive  groups  it  was  decreased.  The
analysis of crystalluria after 28 days of treatment with stone inducing agents
showed that it is markedly increased in the lithiatic group, while it is decreased
in aqueous extract of leaves of Clitoria ternatea treatment.
In the Diuretic study, the urine volume was elevated in the AECT(250
and 500 mg/kg) treatment when compared to the control animals. The Sodium,
potassium, and chloride concentrations were significantly (P<0.01) increased in
the standard and the AECT treatment. Diuretic index is evaluated to assess the
diuretic potential of the plant.
          The exact mechanism of action of the plants is not known.However it
may  be  due  to  following  actions  of  the  plant  Clitoria  ternatea may  be
responsible for the antilithiatic activity.
• By  increasing  using  volume  pH  and  anticalcifying  activity
(diuretic activity) helps in spontaneous passage
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• By balancing the inhibition and promotion of crystallization in
urine 
• Relives the binding mucin of calculi (lithophilic activity)
• By improving renal functions, regulation of oxalate metabolism
• Regulate the crystalloid colloid imbalance and improves the 
renal function
• Improves renal antioxidant status and cell membrane integrity 
and prevent recurrence (antioxidant activity)
• Exert significant anti infective action against major curative 
organisms
• Reveals marked improvement in symptoms of urinary calculi 
like pain,burning micturation and haematuria(analgesic and anti-
inflammatory) (Anubhav Nagal et.al)
              
However,  the  treatment of aqueous extract of  Clitoria ternatea caused
diuresis  and  hastened  the  process  o f  dissolving the  preformed  stones  and
prevention of new stone formation in urinary system.
All these observations enabled us to confirm the inhibitory and curative
potential, of aqueous extract of  Clitoria ternatea on ethylene glycol induced
lithiasis and its diuretic potential. 
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CONCLUSION
The  presented  data  about  various  ion  concentrations  like  calcium,
oxalate, magnesium, phosphate excretion in urine analysis and creatinine, uric
acid,  Blood  urea  nitrogen  (BUN)  in  serum  analysis  indicates  that  the
administration of aqueous Extract of Clitoria ternatea leaves to ethylene glycol
induced  lithiatic  rats  reduced  and  prevented  the  growth  of  urinary  stones,
supporting folk information regarding antilithiatic activity of the plant.
The mechanism underlying this effect is still unknown, but is apparently
related to increased diuresis and lowering of urinary concentrations of stone
forming constituents. These finding, thus prompt the necessity for further study
to carry out the Mechanism of actions related to antilithiatic effect of Aqueous
Extract  of  Clitoria  ternatea leaves.  By  which  more  effective  treatment  for
lithiasis can be achieved.
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